CA2540676A1 - Removable biliary stent - Google Patents
Removable biliary stent Download PDFInfo
- Publication number
- CA2540676A1 CA2540676A1 CA002540676A CA2540676A CA2540676A1 CA 2540676 A1 CA2540676 A1 CA 2540676A1 CA 002540676 A CA002540676 A CA 002540676A CA 2540676 A CA2540676 A CA 2540676A CA 2540676 A1 CA2540676 A1 CA 2540676A1
- Authority
- CA
- Canada
- Prior art keywords
- medical appliance
- appliance
- scaffolding
- medical
- shaped
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2/07—Stent-grafts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2002/041—Bile ducts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/065—Y-shaped blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91525—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/91533—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91566—Adjacent bands being connected to each other connected trough to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/82—Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/86—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
- A61F2/90—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
- A61F2/91—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
- A61F2/915—Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
- A61F2002/9155—Adjacent bands being connected to each other
- A61F2002/91575—Adjacent bands being connected to each other connected peak to trough
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0017—Angular shapes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0018—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in elasticity, stiffness or compressibility
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0039—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in diameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0051—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in tissue ingrowth capacity, e.g. made from both ingrowth-promoting and ingrowth-preventing parts
Abstract
The present invention, in an exemplary embodiment, provides a stent, which combines many of the excellent characteristics of both silicone and metal stents while eliminating the undesirable ones. In particular, a principal objective in accordance with the present invention is to provide a family of stents generally and a biliary stent in particular where the relative hardness/softness of regions of the stent can differ from other regions of t he stent to provide additional patient comfort and resistance to radial forces. An exemplary embodiment also provides a family of stents with novel intersti ce configurations that facilitate flexibility, durability and/or proper installation. Additionally, the biliary stent in accordance with the present invention provides enhanced flow mechanics to ensure the adequate clearance of viscid fluids such as bile.
Description
REMOVABLE BILIARY STENT
FIELD OF INVENTION
The present invention relates generally to medical devices directed to the prevention of luminal occlusion, and more particularly to scents and methods for making and utilizing these stents in the treatment of both benign and malignant conditions wherein the functionality of the stents is determined by geometrical variability of the scaffolding and concomitant interstices.
BACKGROUND OF THE INVENTION
Scents are devices that are inserted into a vessel or passage to keep' the lumen open and prevent closure due to a stricture, external compression, or internal obstruction. In particular, scents are commonly used to keep blood vessels open in the coronary arteries and they are frequently inserted into the ureters to maintain drainage from the kidneys, the bile duct for pancreatic cancer or cholangiocarcinoma or the esophagus for strictures or cancer. Vascular as well as non-vascular scenting has evolved significantly; unfortunately there remain significant limitations with respect to the technology for producing stents suitable to various portions of a patient's anatomy.
Historically, in order to provide a stent with varying characteristics, the scent had to be manufactured from multiple materials, at least one for each characteristic desired. As a result, many of these stents are woven from two or more metals having differing shape-memories for example. Unfortunately, braided stems are vulnerable to premature obsolescence. Moreover, providing multiple material types in a single stent may lead to inconsistent
FIELD OF INVENTION
The present invention relates generally to medical devices directed to the prevention of luminal occlusion, and more particularly to scents and methods for making and utilizing these stents in the treatment of both benign and malignant conditions wherein the functionality of the stents is determined by geometrical variability of the scaffolding and concomitant interstices.
BACKGROUND OF THE INVENTION
Scents are devices that are inserted into a vessel or passage to keep' the lumen open and prevent closure due to a stricture, external compression, or internal obstruction. In particular, scents are commonly used to keep blood vessels open in the coronary arteries and they are frequently inserted into the ureters to maintain drainage from the kidneys, the bile duct for pancreatic cancer or cholangiocarcinoma or the esophagus for strictures or cancer. Vascular as well as non-vascular scenting has evolved significantly; unfortunately there remain significant limitations with respect to the technology for producing stents suitable to various portions of a patient's anatomy.
Historically, in order to provide a stent with varying characteristics, the scent had to be manufactured from multiple materials, at least one for each characteristic desired. As a result, many of these stents are woven from two or more metals having differing shape-memories for example. Unfortunately, braided stems are vulnerable to premature obsolescence. Moreover, providing multiple material types in a single stent may lead to inconsistent
-2-characteristics along the surface area of the stent. This is particularly undesirable when the scent is to be placed in vascular or nonvascular lumens that have been occluded for one reason or another. The stem needs to be stiffer in some regions while more flexible in others.
Additional limitations of existing devices involve the constraint of flow dynamics through the internal diameter because of their scaffolding architecture. In particular, billiary scents can easily become clogged by the stagnation of bile there through depending on exactly where the stent is placed between the liver, the gallbladder and the l0 duodenum.
Therefore, there remains an existing need for a therapeutic scent that can have varying characteristics along its surface area while being stamped, not braded, from a single base material. Moreover, there is a need for such a therapeutic stent where the relative hardness, softness, flexibility, stiffness and radial force can be modified as a function of geometric considerations rather than material considerations. In particular, there is a need for a scent that is divided into zones so as to allow the stent to have predetermined characteristics in one zone and could conceivably have drastically different characteristics in an adjacent zone so as to allow for scents that can be tailored to anatomical lumens in general and the particular lumen topography of a specific patient in particular.
Moreover, a need remains for a stent that is specifically designed to resist adhesion and facilitate the flow of viscid fluids.
SUMMARY OF EXEMPLARY EMBODIMENTS
It is a principal purpose of the present invention to provide a stem, in accordance with an exemplary embodiment of the present invention, which combines many of the excellent characteristics of both silicone and metal scents while eliminating the undesirable ones.
In particular, it is an objective of a preferred embodiment in
Additional limitations of existing devices involve the constraint of flow dynamics through the internal diameter because of their scaffolding architecture. In particular, billiary scents can easily become clogged by the stagnation of bile there through depending on exactly where the stent is placed between the liver, the gallbladder and the l0 duodenum.
Therefore, there remains an existing need for a therapeutic scent that can have varying characteristics along its surface area while being stamped, not braded, from a single base material. Moreover, there is a need for such a therapeutic stent where the relative hardness, softness, flexibility, stiffness and radial force can be modified as a function of geometric considerations rather than material considerations. In particular, there is a need for a scent that is divided into zones so as to allow the stent to have predetermined characteristics in one zone and could conceivably have drastically different characteristics in an adjacent zone so as to allow for scents that can be tailored to anatomical lumens in general and the particular lumen topography of a specific patient in particular.
Moreover, a need remains for a stent that is specifically designed to resist adhesion and facilitate the flow of viscid fluids.
SUMMARY OF EXEMPLARY EMBODIMENTS
It is a principal purpose of the present invention to provide a stem, in accordance with an exemplary embodiment of the present invention, which combines many of the excellent characteristics of both silicone and metal scents while eliminating the undesirable ones.
In particular, it is an objective of a preferred embodiment in
-3-accordance with the present invention to provide a stent that is easily installed, yet in alternative embodiments, removable. Moreover the scent in accordance with this embodiment of the present invention would not cause material infections and may be capable of reducing infection. Therefore, a principal objective of a preferred embodiment in accordance with the present invention is to provide a prosthesis that is suitable for both permanent and temporary use while being easy to insert, reposition and remove.
A principal objective of a preferred embodiment of the present invention is to provide a scent that may be stamped from preferably a single material that is capable of maintaining its axial working length when radially compressed. To this end, the scent does not have a seam that could aggravate luminal tissue. In particular, a scent in accordance with the present invention is formed using a tool that molds the scents outer contour as well as its interstices.
It is yet another objective of an exemplary embodiment of the present invention to provide a scent that can be indicated for the treatment of benign and malignant disease and improve the way clinicians treat malignant obstructions.
Still another objective of the present invention is to provide a scent and method for installing the scent that is economical and suitable for routine purposes. Moreover, the scent will have minimal migration, cause minimal tissue granulation, will not foreshorten after deployment and mucociliary clearance will not be problematic.
Yet another objective of an exemplary embodiment in accordance with the present invention is to provide a prosthesis that will have superior internal to external diameter ratio, superior radial force with dynamic expansion, while being suitable for use in pediatric and adult patients with malignant and benign disease.
A principal objective of a preferred embodiment of the present invention is to provide a scent that may be stamped from preferably a single material that is capable of maintaining its axial working length when radially compressed. To this end, the scent does not have a seam that could aggravate luminal tissue. In particular, a scent in accordance with the present invention is formed using a tool that molds the scents outer contour as well as its interstices.
It is yet another objective of an exemplary embodiment of the present invention to provide a scent that can be indicated for the treatment of benign and malignant disease and improve the way clinicians treat malignant obstructions.
Still another objective of the present invention is to provide a scent and method for installing the scent that is economical and suitable for routine purposes. Moreover, the scent will have minimal migration, cause minimal tissue granulation, will not foreshorten after deployment and mucociliary clearance will not be problematic.
Yet another objective of an exemplary embodiment in accordance with the present invention is to provide a prosthesis that will have superior internal to external diameter ratio, superior radial force with dynamic expansion, while being suitable for use in pediatric and adult patients with malignant and benign disease.
-4-A principal objective of an exemplary scent in accordance with the present invention is to provide a family of scents where the relative hardness/softness of regions of the stent can differ from other regions of the scent to provide additional patient comfort and resistance to radial forces.
An additional objective in accordance with an exemplary embodiment is to provide a family of stents with novel interstice configurations that facilitate flexibility, durability and/or proper installation.
Still another objective of a preferred embodiment of the present invention is to provide a self-expanding stent having the above benefits that also defines a plurality of apertures at the termini of the scent for, inter alia, removal of the scent.
An additional objective in accordance with a preferred embodiment of the present invention is to provide a billiary scent specifically designed to facilitate fluid flow dynamics generally and bile flow in particular. In the furtherance of this and other objectives, a substantially cone shaped billiary scent is provided that harnesses the benefits of fluid mechanics to prevent undesireable obstruction of the scent lumen.
Further objectives, features and advantages of the invention will be apparent from the following detailed description taken in conjunction with the accompanying drawings.
BRIEF DESCRIPTION OF THE FIGURES
FIG. 1 shows a side perspective view of an exemplary stent in accordance with the present invention.
FIG. 2 shows a side perspective view of a single zone of the scent shown in FIG. 1.
An additional objective in accordance with an exemplary embodiment is to provide a family of stents with novel interstice configurations that facilitate flexibility, durability and/or proper installation.
Still another objective of a preferred embodiment of the present invention is to provide a self-expanding stent having the above benefits that also defines a plurality of apertures at the termini of the scent for, inter alia, removal of the scent.
An additional objective in accordance with a preferred embodiment of the present invention is to provide a billiary scent specifically designed to facilitate fluid flow dynamics generally and bile flow in particular. In the furtherance of this and other objectives, a substantially cone shaped billiary scent is provided that harnesses the benefits of fluid mechanics to prevent undesireable obstruction of the scent lumen.
Further objectives, features and advantages of the invention will be apparent from the following detailed description taken in conjunction with the accompanying drawings.
BRIEF DESCRIPTION OF THE FIGURES
FIG. 1 shows a side perspective view of an exemplary stent in accordance with the present invention.
FIG. 2 shows a side perspective view of a single zone of the scent shown in FIG. 1.
5 PCT/US2004/031906 FIG. 3 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2.
FIG. 4 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative octagonal connection member.
FIG. 5 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative omega shaped connection member.
FIG. 6 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative M shaped connection member.
FIG. 7 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative S shaped connection member.
FIG. 3 shows a magnified view of the scaffolding and interstice topology of the medical appliance shown in FIG. 1.
FIG. 9 shows a magnified portion of the scaffolding and interstice topology of the medical appliance of FIG. 1, showing how modifications in geometric dimensions affect functionality.
FIG. 10 shows an enlarged perspective view of an exemplary connector wherein the connector is oriented closer to one zone than another.
FIG. 11 shows an enlarged perspective view of an exemplary connector wherein the connector is oriented closer to the opposite zone as the connector shown in FIG. 10.
FIG. 12 shows an enlarged perspective view of an exemplary connector wherein the connector is oriented substantially equidistant between two zones.
FIG. 13 is a perspective view of a substantially cone shaped biliary scent in accordance with the present invention.
FIG. 4 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative octagonal connection member.
FIG. 5 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative omega shaped connection member.
FIG. 6 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative M shaped connection member.
FIG. 7 shows an enlarged perspective view of the interstices of an exemplary zone as shown in FIG. 2 showing an alternative S shaped connection member.
FIG. 3 shows a magnified view of the scaffolding and interstice topology of the medical appliance shown in FIG. 1.
FIG. 9 shows a magnified portion of the scaffolding and interstice topology of the medical appliance of FIG. 1, showing how modifications in geometric dimensions affect functionality.
FIG. 10 shows an enlarged perspective view of an exemplary connector wherein the connector is oriented closer to one zone than another.
FIG. 11 shows an enlarged perspective view of an exemplary connector wherein the connector is oriented closer to the opposite zone as the connector shown in FIG. 10.
FIG. 12 shows an enlarged perspective view of an exemplary connector wherein the connector is oriented substantially equidistant between two zones.
FIG. 13 is a perspective view of a substantially cone shaped biliary scent in accordance with the present invention.
-6-FIG. 14 is aerial view of the scent of FIG. 13 along line 14 - 14, showing the lumen thereof and the dimensional mismatch between the lumen diameter at the proximal and distal ends of the scent.
FIG. 15 is an aerial view of the scent of FIG. 13 from the opposite end of that shown in FIG. 14.
DETAILED DESCRIPTION OF AN EMBODIMENT
A preferred embodiment of the scent, in accordance with the present invention, provides a scent that prevents epithelialization of the scent and is not subject to premature elongation and foreshortening but is capable of engaging the desired implantation location. The stent also retains its axial length while undergoing radial compression.
The scent is preferably formed from a composite material selected from the group consisting essentially of Ni, C, Co, Cu, Cr, H, Fe, Nb, O, Ti and combinations thereof. The composite material is generally formed into a compressed tube from which the scent is etched and is formed on a suitable shaping device to give the stent the desired external geometry. Both the synthetic collar techniques and in vitro valuation techniques show the remarkable ability of stents in accordance with the present invention to convert acting force into 2o deformation work absorbed by the angled structure, which prevents excessive scaffolding stress and premature material fatigue and accelerated obsolescence.
Though one skilled in the stent engineering art, once apprised of the present application, would be able to manufacture a scent consistent with the present invention by other methods, a preferred method of manufacturing such stents follows. As stated above a composite material is selected and a blank is formed there from. The blank is preferably laser etched and the etch work is generally verified for accuracy using visual recording microscopy. Dimensional measurements are taken to ensure strut thickness, segment angles, zone placement, etc. Moreover, the scent is preferably formed on a shaping tool that has substantially the desired contour of the external scent dimensions.
In the event the scent is to be shaped to the dimensions of a particular lumen, optical photography and/or optical videography of the target lumen may be conducted prior to scent formation. The geometry of corresponding zones and connector regions of the scent then can be etched and formed in accordance with the requirements l0 of that target lumen. For example, if the stent were designed for the trachea, which has a substantially D shaped lumen and additionally the middle zones needed to be softer than the end zones, the scent could be designed to those specifications. In particular, if the topography of the trachea of a particular patient is captured optically and the appropriate dimension provided, a patient specific prosthesis could be engineered. These techniques can be adapted to other non-vascular lumen but is very well suited for vascular applications where patient specific topography is a function of a variety of factors such as genetics, lifestyle, etc.
It should be pointed out that unlike the use of differing shape memory materials to change regions of a stent, scents in accordance with the present invention can take on an infinite number of characteristic combinations as zones and segments within a zone can be modified by changing angles, segment lengths and segment thicknesses during the etching and forming stages of scent engirieering or during post formation processing and polishing steps. Moreover, by modifying the geometry of the connectors between zones, addition functionality may be achieved.
Exemplary scents 10 in accordance with the present invention are shown in FIGS. 1-3 showing the preferred interstice geometry. Not _g_ shown are a wide variety of interstice geometries that are also acceptable alternatives to the preferred, namely, U, V, W, Z, S and X
geometries to name a few.
The scent 10 also is formed of memory metal and preferably has unique geometrical interstices that are laser etched therein. However, other conventional ways of forming interstices in unitary scents, though not equivalent are contemplated, may be employed and would be within the skill set of one in the art.
It cannot be overemphasized, however, that this does not mean the knowledge that changes in the geometry of interstices affect scent functionality is currently known in the art. To the contrary, the present inventors discovered the interrelation between interstice geometry, width, length and relative resistance to torsional stress and radial force.
In fact, it can be said that the stent 10 has circumferential bands extending perpendicularly with respect to the luminal device's longitudinal axis. These bands are referred to generally as zones. A
connector 50 connects these bands to one another; the connector 50 is an additional means for adjusting stent functionality. In particular, the connector 50 defines a substantially U shaped member, but could define other geometries such as U, V, W, Z, S and X to name a few.
In a standard orientation, as shown particularly in FIG. 1, the substantially U-shape connector comprises preferably two leg members 52 & 56 and a crossing member 54 that connects with and extends perpendicularly at preferably 90° angles with respect to the leg members 52 & 56. It must be noted that alternative angles may be provided without departing materially from the invention. The present inventors discovered that if you modify the length of the crossing member 54 and/or the leg members 52 & 56 and/or the angle ~y at which the crossing member 54 and the leg members 52 & 56 intersect, the relative hardness/softness, radial force and/or flexibility of the scent _g_ could be modified. The angles ~y can be modified at varying acute angles short of 90° or varying obtuse angles greater than 90°.
The incremental changes correspondingly change certain characteristics of the stem 10. As a result, different zones of the stent 10 can be given 5 different rigidities to improve patient comfort and for example, in airway stents, to facilitate luminal patency. Moreover, various anatomical lumens may need different degrees of scent rigidity. As a result, stents 10 in accordance with the present invention can be manufactured to exacting specifications to contour properly to various l0 lumens in a patient's anatomy, which may need varying levels of structural support from the medical appliance.
As depicted in FIGS. 10-12; by adjusting the distance between the connector 50 and for examples Zones 2 and 3 between which connector 50 resides, the way in which the stent reacts to strain can be modified. By way of non-limiting example, if the connector 40 is oriented closer to zone 3 than to zone 2, the scent will be less flexible and be able to withstand greater radial force. Alternatively, if the connector is equidistant between Zones 2 and 3, the scent will be more flexible and be able to withstand less radial force. Please note that these differences are relative to a neutrally located connector 40. The behavior is a function of distance and as a result varies along a continuum with respect to the connector's orientation between the medium between zones and the tip of each zone. Moreover, within by varying the number of connectors 40 that connect the zones to one another, functionality can be impacted. In particular, the fewer the number of connectors connecting the zones the more torsional flexibility the scent will have. The converse will generally hold true with respect to a greater number of connectors.
Referring now to FIG. 2, stent 10 is shown having several bands within a zone forming substantially arrow shaped regions. In particular, each arrow shaped band preferably comprises a forward angle ~ and a rear angle a. The forward angle ~ is formed by the intersection of two legs 24 & 25. Legs 24 & 25 connect at first ends 26 & 27 to form the head 22 of angle ~. Second ends 28 & 29 of legs 24 & 25 terminate at connectors 40. Connector 40 connects the legs 24 & 25 of forward angle ~ to the legs 32 & 34 of rear angle a via intermediary leg 36.
Where legs 32, 34 & 36 connect is the head 30, which defines an aperture 38 for installing suture.
Connector 40, which serves a similar purpose as connector 50 l0 also has a crossing member 44 that connects leg members 42 & 46 at a predetermined angle b. As discussed above, since form follows function for scents prepared through this novel method, by changing the degrees of angles a, ~, 8 & y, scent characteristics can be modified.
Moreover, by changing the leg lengths of all the previously discussed legs or individual legs separately, additional scent characteristics can be obtained. The beauty of this system is that the desired characteristics can be determined prior to forming the scent and by staying within certain forming parameters, the scent can be formed, crimped, delivered and deployed with confidence that the desired functionality with result. This is important in light of the fact that both vascular and nonvascular lumen have unique topography. As a result, methods and devices in accordance with the present invention usher in the ability to tailor prosthesis to anatomical tissue in general and particular patient anatomy in particular.
The U shaped connectors 40 & 50 have a crossing member and at least two leg members, respectively. The present inventors discovered that if you increase/decrease the length of leg members and/or increase/decrease the length of crossing members and/or vary the angle at which crossing members and leg members intersect, you affect the functionality of the scent. In particular, the shorter the length of the leg members, the less flexibility available in that portion of the scent. Taking particular note of FIG. 3, by way of example only, if you want to decrease the amount of torsional flexibility of the scent 10, you would have to modify the connector 40 so that the legs 42 & 46 are longer than shown and that the angle 8 formed by legs 42 & 46 and crossing member 44, respectively, is slightly greater than 90°.
Alternatively, the length of the crossing member 44 can impact the functionality of the stent as well. The scent can be made more rigid by shortening crossing member 44 or the scent may be made more flexible by lengthening crossing member 44. It should be noted that the combination of the changes of leg lengths, crossing member lengths, angle variations, shapes and number of connectors provide the stent with the ability to conform to specific lumens in the anatomy of a patient. The result is a form fitting medical prosthesis that may be tailored to specific anatomical lumens in general and to the anatomical lumens of an individual patient in particular.
In a preferred embodiment, the modification of interstice geometries and manipulation of the U shaped connection member to achieve variable stent functionality is provided. The rigidity of the stent scaffolding or interstice matrix along with the torsionality of the scent itself is principally a function of these modifications. In an exemplary embodiment, the stents relative flexibility can be rated soft, medium or hard based on the degree of flex and torsionality. The less torsionality and flex in the stent the harder the scent is rated.
An exemplary stent in accordance with the present invention with relatively great torsionality and radial flexibility would be rated soft.
An exemplary soft rated stent comprises distance between U shaped connectors of about 4.5 ~,m in the compressed state (i.e., contracted in the 3mm tube subject to laser etching). Moreover, the length of the crossing member is preferably about 1.0 ~,m. The lengths of the leg members are preferably about 1.5 wm in length. Additionally the leg members may further comprise feet that attached to the remainder of the scent scaffolding. The feet can be adjusted from a standard length of about 0.25 ~,m to further adjust the characteristics of the scent. There is additionally a substantially rectangular member incorporated in the U shaped connector with similar capacity for variability. The variability factors and results of modifying the dimensions of the substantially rectangular members are similar to those evinced by leg length dimensional modifications.
Referring now to FIGS. 8 and 9, where like numerals refer to like parts, luminal stent 810 is shown having substantially U shaped connectors 818 having a crossing member 819a and at least two leg members 819b-c respectively. The present inventors discovered that if you increase/decrease the length of leg member 819b and/or 819c, increase/decrease the length of crossing member 819a, and/or vary the angle at which crossing member 819a and leg members 819b-c intersect, you affect the functionality of the stent. In particular, the shorter the length of leg members 819a-b the less flexibility available in that portion of the stent. Taking particular note of FIG. 9, by way of example only, if you want to decrease the amount of torsional flexibility of the luminal stent 910, you would have to modify the desired portion of the scent to resemble 918f. However, if you want a stiffer appliance 910, you would have a configuration analogous to that of 918a.
By way of example, but not to be construed in any way as limiting, the softness index or relative flexibility can be increase by increasing the various lengths discussed above. For example, by increasing the length of the legs and crossing members of the U
shaped connector, flexibility increases. However, with respect to the distance between U shaped members and distance between 3o interstices in a preferred stent embodiment, there is an inverse correlation between length and softness. This relative softness/hardness indexing as a corollary of interstice dimensions is a novel aspect of preferred embodiment of the present invention. As a practical rule of thumb, longer leg lengths coupled with acute angles provide for greater flexibility. Conversely, shorter leg lengths and more obtuse angles provide more rigidity. By way of non-limiting example, a U shaped connector with short legs deviating from the crossing member at angles greater than 90°, will be extremely rigid and resistant to torsional strain as compared to a U shaped connector with longer legs diverging from the crossing member at angles less than 90°.
In addition to the length and spacing differences, the interstices themselves may define various shapes that by their very nature afford novel functionality to the stent. The changes of functionality, however, are more a function of the dimensional differences of the various shapes rather than a function of the shapes themselves. Therefore, it is important to keep in mind that the dimensional differences discussed in the previous paragraph are determinative of the functionality accorded the stent by the varying interstice geometries. It is for this reason that one of ordinary skill in the art, after being apprised of the present invention, would be able to conceive of a number of interstice geometries to satisfy certain functionality criteria by keeping certain dimensional parameters constant.
Experiments have shown that viscid fluids such as bile can be very adhesive in implantable devices due to charge, density and drag coefficient. The drag exerted on the scent scaffolding from moving fluid is directly proportional to the density of the fluid. Density describes the mass per unit volume. Therefore, the density of bile increases the likelihood that it can become stagnant in a scented lumen. As a result, the present inventors harnessed principles of fluid mechanics to develop a scent that can reduce drag by facilitating the flow rate of the fluid and the surface area of evacuation.
Making specific reference to FIGS. 13-15, an exemplary scent in accordance v~iith the present invention provides a substantially cone shaped scaffolding to facilitate bile flow. In particular, the distal end of the scent has a larger lumen diameter than the proximal end.
However, it should be noted that in preferred embodiments the distal end still has a lumen diameter that is less than the greatest lumen diameter along the device. In other vyords, the distal end is oriented inward toward the lumen such that the ends do not necessarily come into contact with tissue in order to facilitate removability.
Moreover, removability is enhanced by providing apertures 30 and 120 defining eyelets through which suture may be threaded in order to purse string the scent for easier removal. The eyelets are preferably large enough to receive between 6-0 and 4-0 suture. It should also be noted that the eyelets 30 and 120, though shown at the distal and proximal ends of the stent may be configured along the longitudinal expanse there between in order to vary the degree of radial compression used to remove the stent.
As an adjunct to the biliary stent, in cases where the scent is placed in the lower intestinal tract, an annular ring should be provided to prevent regeneration and obstruction at the Sphincter of Oddi. In many cases, the Sphincter of Oddi is dilated, burned or made inoperable by various means in order to alleviate an obstruction and to facilitate stenting. Unfortunately, the sphincter often grows back or regenerates in some fashion that causes problems for the patient. By providing an annular ring to keep the lumen open, the efficacy of scenting is enhanced.
The present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative, and not restrictive. The scope of the invention is, therefore, indicated by the appended claims, rather than by the foregoing description. All changes, which come within the meaning and range of equivalency of the claims, are to be embraced within their scope.
FIG. 15 is an aerial view of the scent of FIG. 13 from the opposite end of that shown in FIG. 14.
DETAILED DESCRIPTION OF AN EMBODIMENT
A preferred embodiment of the scent, in accordance with the present invention, provides a scent that prevents epithelialization of the scent and is not subject to premature elongation and foreshortening but is capable of engaging the desired implantation location. The stent also retains its axial length while undergoing radial compression.
The scent is preferably formed from a composite material selected from the group consisting essentially of Ni, C, Co, Cu, Cr, H, Fe, Nb, O, Ti and combinations thereof. The composite material is generally formed into a compressed tube from which the scent is etched and is formed on a suitable shaping device to give the stent the desired external geometry. Both the synthetic collar techniques and in vitro valuation techniques show the remarkable ability of stents in accordance with the present invention to convert acting force into 2o deformation work absorbed by the angled structure, which prevents excessive scaffolding stress and premature material fatigue and accelerated obsolescence.
Though one skilled in the stent engineering art, once apprised of the present application, would be able to manufacture a scent consistent with the present invention by other methods, a preferred method of manufacturing such stents follows. As stated above a composite material is selected and a blank is formed there from. The blank is preferably laser etched and the etch work is generally verified for accuracy using visual recording microscopy. Dimensional measurements are taken to ensure strut thickness, segment angles, zone placement, etc. Moreover, the scent is preferably formed on a shaping tool that has substantially the desired contour of the external scent dimensions.
In the event the scent is to be shaped to the dimensions of a particular lumen, optical photography and/or optical videography of the target lumen may be conducted prior to scent formation. The geometry of corresponding zones and connector regions of the scent then can be etched and formed in accordance with the requirements l0 of that target lumen. For example, if the stent were designed for the trachea, which has a substantially D shaped lumen and additionally the middle zones needed to be softer than the end zones, the scent could be designed to those specifications. In particular, if the topography of the trachea of a particular patient is captured optically and the appropriate dimension provided, a patient specific prosthesis could be engineered. These techniques can be adapted to other non-vascular lumen but is very well suited for vascular applications where patient specific topography is a function of a variety of factors such as genetics, lifestyle, etc.
It should be pointed out that unlike the use of differing shape memory materials to change regions of a stent, scents in accordance with the present invention can take on an infinite number of characteristic combinations as zones and segments within a zone can be modified by changing angles, segment lengths and segment thicknesses during the etching and forming stages of scent engirieering or during post formation processing and polishing steps. Moreover, by modifying the geometry of the connectors between zones, addition functionality may be achieved.
Exemplary scents 10 in accordance with the present invention are shown in FIGS. 1-3 showing the preferred interstice geometry. Not _g_ shown are a wide variety of interstice geometries that are also acceptable alternatives to the preferred, namely, U, V, W, Z, S and X
geometries to name a few.
The scent 10 also is formed of memory metal and preferably has unique geometrical interstices that are laser etched therein. However, other conventional ways of forming interstices in unitary scents, though not equivalent are contemplated, may be employed and would be within the skill set of one in the art.
It cannot be overemphasized, however, that this does not mean the knowledge that changes in the geometry of interstices affect scent functionality is currently known in the art. To the contrary, the present inventors discovered the interrelation between interstice geometry, width, length and relative resistance to torsional stress and radial force.
In fact, it can be said that the stent 10 has circumferential bands extending perpendicularly with respect to the luminal device's longitudinal axis. These bands are referred to generally as zones. A
connector 50 connects these bands to one another; the connector 50 is an additional means for adjusting stent functionality. In particular, the connector 50 defines a substantially U shaped member, but could define other geometries such as U, V, W, Z, S and X to name a few.
In a standard orientation, as shown particularly in FIG. 1, the substantially U-shape connector comprises preferably two leg members 52 & 56 and a crossing member 54 that connects with and extends perpendicularly at preferably 90° angles with respect to the leg members 52 & 56. It must be noted that alternative angles may be provided without departing materially from the invention. The present inventors discovered that if you modify the length of the crossing member 54 and/or the leg members 52 & 56 and/or the angle ~y at which the crossing member 54 and the leg members 52 & 56 intersect, the relative hardness/softness, radial force and/or flexibility of the scent _g_ could be modified. The angles ~y can be modified at varying acute angles short of 90° or varying obtuse angles greater than 90°.
The incremental changes correspondingly change certain characteristics of the stem 10. As a result, different zones of the stent 10 can be given 5 different rigidities to improve patient comfort and for example, in airway stents, to facilitate luminal patency. Moreover, various anatomical lumens may need different degrees of scent rigidity. As a result, stents 10 in accordance with the present invention can be manufactured to exacting specifications to contour properly to various l0 lumens in a patient's anatomy, which may need varying levels of structural support from the medical appliance.
As depicted in FIGS. 10-12; by adjusting the distance between the connector 50 and for examples Zones 2 and 3 between which connector 50 resides, the way in which the stent reacts to strain can be modified. By way of non-limiting example, if the connector 40 is oriented closer to zone 3 than to zone 2, the scent will be less flexible and be able to withstand greater radial force. Alternatively, if the connector is equidistant between Zones 2 and 3, the scent will be more flexible and be able to withstand less radial force. Please note that these differences are relative to a neutrally located connector 40. The behavior is a function of distance and as a result varies along a continuum with respect to the connector's orientation between the medium between zones and the tip of each zone. Moreover, within by varying the number of connectors 40 that connect the zones to one another, functionality can be impacted. In particular, the fewer the number of connectors connecting the zones the more torsional flexibility the scent will have. The converse will generally hold true with respect to a greater number of connectors.
Referring now to FIG. 2, stent 10 is shown having several bands within a zone forming substantially arrow shaped regions. In particular, each arrow shaped band preferably comprises a forward angle ~ and a rear angle a. The forward angle ~ is formed by the intersection of two legs 24 & 25. Legs 24 & 25 connect at first ends 26 & 27 to form the head 22 of angle ~. Second ends 28 & 29 of legs 24 & 25 terminate at connectors 40. Connector 40 connects the legs 24 & 25 of forward angle ~ to the legs 32 & 34 of rear angle a via intermediary leg 36.
Where legs 32, 34 & 36 connect is the head 30, which defines an aperture 38 for installing suture.
Connector 40, which serves a similar purpose as connector 50 l0 also has a crossing member 44 that connects leg members 42 & 46 at a predetermined angle b. As discussed above, since form follows function for scents prepared through this novel method, by changing the degrees of angles a, ~, 8 & y, scent characteristics can be modified.
Moreover, by changing the leg lengths of all the previously discussed legs or individual legs separately, additional scent characteristics can be obtained. The beauty of this system is that the desired characteristics can be determined prior to forming the scent and by staying within certain forming parameters, the scent can be formed, crimped, delivered and deployed with confidence that the desired functionality with result. This is important in light of the fact that both vascular and nonvascular lumen have unique topography. As a result, methods and devices in accordance with the present invention usher in the ability to tailor prosthesis to anatomical tissue in general and particular patient anatomy in particular.
The U shaped connectors 40 & 50 have a crossing member and at least two leg members, respectively. The present inventors discovered that if you increase/decrease the length of leg members and/or increase/decrease the length of crossing members and/or vary the angle at which crossing members and leg members intersect, you affect the functionality of the scent. In particular, the shorter the length of the leg members, the less flexibility available in that portion of the scent. Taking particular note of FIG. 3, by way of example only, if you want to decrease the amount of torsional flexibility of the scent 10, you would have to modify the connector 40 so that the legs 42 & 46 are longer than shown and that the angle 8 formed by legs 42 & 46 and crossing member 44, respectively, is slightly greater than 90°.
Alternatively, the length of the crossing member 44 can impact the functionality of the stent as well. The scent can be made more rigid by shortening crossing member 44 or the scent may be made more flexible by lengthening crossing member 44. It should be noted that the combination of the changes of leg lengths, crossing member lengths, angle variations, shapes and number of connectors provide the stent with the ability to conform to specific lumens in the anatomy of a patient. The result is a form fitting medical prosthesis that may be tailored to specific anatomical lumens in general and to the anatomical lumens of an individual patient in particular.
In a preferred embodiment, the modification of interstice geometries and manipulation of the U shaped connection member to achieve variable stent functionality is provided. The rigidity of the stent scaffolding or interstice matrix along with the torsionality of the scent itself is principally a function of these modifications. In an exemplary embodiment, the stents relative flexibility can be rated soft, medium or hard based on the degree of flex and torsionality. The less torsionality and flex in the stent the harder the scent is rated.
An exemplary stent in accordance with the present invention with relatively great torsionality and radial flexibility would be rated soft.
An exemplary soft rated stent comprises distance between U shaped connectors of about 4.5 ~,m in the compressed state (i.e., contracted in the 3mm tube subject to laser etching). Moreover, the length of the crossing member is preferably about 1.0 ~,m. The lengths of the leg members are preferably about 1.5 wm in length. Additionally the leg members may further comprise feet that attached to the remainder of the scent scaffolding. The feet can be adjusted from a standard length of about 0.25 ~,m to further adjust the characteristics of the scent. There is additionally a substantially rectangular member incorporated in the U shaped connector with similar capacity for variability. The variability factors and results of modifying the dimensions of the substantially rectangular members are similar to those evinced by leg length dimensional modifications.
Referring now to FIGS. 8 and 9, where like numerals refer to like parts, luminal stent 810 is shown having substantially U shaped connectors 818 having a crossing member 819a and at least two leg members 819b-c respectively. The present inventors discovered that if you increase/decrease the length of leg member 819b and/or 819c, increase/decrease the length of crossing member 819a, and/or vary the angle at which crossing member 819a and leg members 819b-c intersect, you affect the functionality of the stent. In particular, the shorter the length of leg members 819a-b the less flexibility available in that portion of the stent. Taking particular note of FIG. 9, by way of example only, if you want to decrease the amount of torsional flexibility of the luminal stent 910, you would have to modify the desired portion of the scent to resemble 918f. However, if you want a stiffer appliance 910, you would have a configuration analogous to that of 918a.
By way of example, but not to be construed in any way as limiting, the softness index or relative flexibility can be increase by increasing the various lengths discussed above. For example, by increasing the length of the legs and crossing members of the U
shaped connector, flexibility increases. However, with respect to the distance between U shaped members and distance between 3o interstices in a preferred stent embodiment, there is an inverse correlation between length and softness. This relative softness/hardness indexing as a corollary of interstice dimensions is a novel aspect of preferred embodiment of the present invention. As a practical rule of thumb, longer leg lengths coupled with acute angles provide for greater flexibility. Conversely, shorter leg lengths and more obtuse angles provide more rigidity. By way of non-limiting example, a U shaped connector with short legs deviating from the crossing member at angles greater than 90°, will be extremely rigid and resistant to torsional strain as compared to a U shaped connector with longer legs diverging from the crossing member at angles less than 90°.
In addition to the length and spacing differences, the interstices themselves may define various shapes that by their very nature afford novel functionality to the stent. The changes of functionality, however, are more a function of the dimensional differences of the various shapes rather than a function of the shapes themselves. Therefore, it is important to keep in mind that the dimensional differences discussed in the previous paragraph are determinative of the functionality accorded the stent by the varying interstice geometries. It is for this reason that one of ordinary skill in the art, after being apprised of the present invention, would be able to conceive of a number of interstice geometries to satisfy certain functionality criteria by keeping certain dimensional parameters constant.
Experiments have shown that viscid fluids such as bile can be very adhesive in implantable devices due to charge, density and drag coefficient. The drag exerted on the scent scaffolding from moving fluid is directly proportional to the density of the fluid. Density describes the mass per unit volume. Therefore, the density of bile increases the likelihood that it can become stagnant in a scented lumen. As a result, the present inventors harnessed principles of fluid mechanics to develop a scent that can reduce drag by facilitating the flow rate of the fluid and the surface area of evacuation.
Making specific reference to FIGS. 13-15, an exemplary scent in accordance v~iith the present invention provides a substantially cone shaped scaffolding to facilitate bile flow. In particular, the distal end of the scent has a larger lumen diameter than the proximal end.
However, it should be noted that in preferred embodiments the distal end still has a lumen diameter that is less than the greatest lumen diameter along the device. In other vyords, the distal end is oriented inward toward the lumen such that the ends do not necessarily come into contact with tissue in order to facilitate removability.
Moreover, removability is enhanced by providing apertures 30 and 120 defining eyelets through which suture may be threaded in order to purse string the scent for easier removal. The eyelets are preferably large enough to receive between 6-0 and 4-0 suture. It should also be noted that the eyelets 30 and 120, though shown at the distal and proximal ends of the stent may be configured along the longitudinal expanse there between in order to vary the degree of radial compression used to remove the stent.
As an adjunct to the biliary stent, in cases where the scent is placed in the lower intestinal tract, an annular ring should be provided to prevent regeneration and obstruction at the Sphincter of Oddi. In many cases, the Sphincter of Oddi is dilated, burned or made inoperable by various means in order to alleviate an obstruction and to facilitate stenting. Unfortunately, the sphincter often grows back or regenerates in some fashion that causes problems for the patient. By providing an annular ring to keep the lumen open, the efficacy of scenting is enhanced.
The present invention may be embodied in other specific forms without departing from its spirit or essential characteristics. The described embodiments are to be considered in all respects only as illustrative, and not restrictive. The scope of the invention is, therefore, indicated by the appended claims, rather than by the foregoing description. All changes, which come within the meaning and range of equivalency of the claims, are to be embraced within their scope.
Claims (50)
1. A medical appliance for placement within a portion of the anatomy of a patient, the appliance comprising:
a scaffolding, the scaffolding configured to define a substantially cylindrical member having a proximal end and a distal end having a internal diameter larger than that of the proximal end and the substantially cylindrical member extending longitudinally there between, forming a lumen there through, such that when pressure is exerted along varying points of the longitudinal extension of the appliance, the appliance does not undesirably foreshorten or elongate.
a scaffolding, the scaffolding configured to define a substantially cylindrical member having a proximal end and a distal end having a internal diameter larger than that of the proximal end and the substantially cylindrical member extending longitudinally there between, forming a lumen there through, such that when pressure is exerted along varying points of the longitudinal extension of the appliance, the appliance does not undesirably foreshorten or elongate.
2. The medical appliance of claim 1, wherein along the longitudinal extension of the appliance, the scaffolding forms geometrical patterns.
3. The medical appliance of claim 2, wherein the scaffolding further comprises a coating coupled with the scaffolding, the coating of sufficient thickness to prevent the medical appliance from becoming epithelialized when installed in the desired portion of the patient's anatomy.
4. The medical appliance of claim 3, wherein the coating does not inhibit flexing or radial expansion of the medical appliance.
5. The medical appliance of claim 4, wherein the coating is coupled with the medical appliance.
6. The medical appliance of claim 2, wherein the dimensions of the scaffolding geometry determine torsionality of the medical appliance.
7. The medical appliance of claim 1, wherein the scaffolding is formed of a memory capable alloy.
8. The medical appliance of claim 7, wherein the scaffolding is electropolished.
9. The medical appliance of claim 1, wherein the scaffolding of the medical appliance further comprises a plurality of eyelets there through for receiving suture.
10. The medical appliance of claim 2, further comprising a connector coupled with portions of the geometrical patterns, the connector comprising a crossing member and a plurality of leg members extending from the crossing member.
11. The medical appliance of claim 10, wherein the connector further comprises a rectangular detent extending from a leg thereof.
12. The medical appliance of claim 10, wherein the length of the leg members and the degree of the angle at which the legs extend from the crossing member determines the relative flexibility of the medical appliance.
13. The medical appliance of claim 12, wherein the angle at which the leg members extend from the crossing member is greater than 90°.
14. The medical appliance of claim 13, wherein the medical appliance is relatively rigid.
15. The medical appliance of claim 13, wherein the angle at which the leg members extend from the crossing member is 90° or less.
16. The medical appliance of claim 14, wherein the medical appliance is relatively flexible.
17. The medical appliance of claim 2, wherein the geometrical patterns are substantially U-shaped.
18. The medical appliance of claim 2, wherein the geometrical patterns are substantially W-shaped.
19. The medical appliance of claim 2, wherein the geometrical patterns are substantially V-shaped.
20. The medical appliance of claim 2, wherein the geometrical patterns are substantially Z-shaped.
21. The medical appliance of claim 2, wherein the geometrical patterns are substantially S-shaped.
22. The medical appliance of claim 2, wherein the geometrical patterns are substantially X-shaped.
23. The medical appliance of claim 1, further comprising an additional distal end wherein the medical appliance forms a substantially Y-shape.
24. The medical appliance of claim 23, wherein along the longitudinal extension of the appliance, the scaffolding forms geometrical patterns.
25. The medical appliance of claim 24, wherein the scaffolding further comprises a coating coupled with the scaffolding, the coating of sufficient thickness to prevent the medical appliance from becoming epithelialized when installed in the desired portion of the patient's anatomy.
26. The medical appliance of claim 25, wherein the dimensions of the scaffolding geometry determine torsionality of the medical appliance.
27. The medical appliance of claim 25, wherein the scaffolding is formed of a memory capable alloy.
28. The medical appliance of claim 26, wherein the scaffolding is electropolished.
29. The medical appliance of claim 25, wherein near the distal and proximal ends of the scaffolding the medical appliance further comprise a plurality of flanges that define apertures there through.
30. The medical appliance of claim 23, further comprising a connector member coupled with portions of the geometrical patterns, the connector comprising a crossing member and a plurality of leg members extending from the crossing member.
31. The medical appliance of claim 30, wherein the connector further comprises a rectangular detent extending from a leg thereof.
32. The medical appliance of claim 30, wherein the length of the leg members or the degree of the angle at which the legs extend from the crossing member positively contributes to the relative flexibility of the medical appliance.
33. The medical appliance of claim 32, wherein the angle at which the leg members extend from the crossing member is greater than 90°.
34. The medical appliance of claim 33, wherein the medical appliance is relatively rigid.
35. The medical appliance of claim 32, wherein the angle at which the leg members extend fro the crossing member is 90° or less.
36. The medical appliance of claim 35, wherein the medical appliance is relatively flexible.
37. The medical appliance of claim 23, wherein the geometrical patterns are substantially U-shaped.
38. The medical appliance of claim 23, wherein the geometrical patterns are substantially W-shaped.
39. The medical appliance of claim 23, wherein the geometrical patterns are substantially V-shaped.
40. The medical appliance of claim 23, wherein the geometrical patterns are substantially Z-shaped.
41. The medical appliance of claim 23, wherein the geometrical patterns are substantially S-shaped.
42. The medical appliance of claim 23, wherein the geometrical patterns are substantially X-shaped.
43. A method of treating a patient suffering from luminal irregularities, comprising the steps of:
providing a medical appliance comprising a scaffolding, the scaffolding configured to define a substantially cylindrical member having a proximal end and a distal end having a internal diameter larger than that of the proximal end and the substantially cylindrical member extending longitudinally there between, forming a lumen there through, such that when pressure is exerted along varying points of the longitudinal extension of the appliance, the appliance does not undesirably foreshorten or elongate;
installing the medical appliance in a preferred location of the anatomy of the patient; and activating the expansion of the medical appliance in the desired location.
providing a medical appliance comprising a scaffolding, the scaffolding configured to define a substantially cylindrical member having a proximal end and a distal end having a internal diameter larger than that of the proximal end and the substantially cylindrical member extending longitudinally there between, forming a lumen there through, such that when pressure is exerted along varying points of the longitudinal extension of the appliance, the appliance does not undesirably foreshorten or elongate;
installing the medical appliance in a preferred location of the anatomy of the patient; and activating the expansion of the medical appliance in the desired location.
44. The method of claim 43, wherein the preferred location is a non-vascular lumen.
45. The method of claim 44, further comprising the step of removing the medical appliance from the anatomy of the patient.
46. The method of claim 44, wherein the medical appliance further comprises anti-microbial agents coupled therewith.
47. The method of claim 44, wherein the medical appliance further comprises chemotherapeutic agents coupled therewith.
48. The medical appliance of claim 43, further comprising an additional distal end wherein the medical appliance forms a substantially Y-shape.
49. A method of removing a medical appliance from a patient, comprising the steps of:
locating the medical appliance comprising a scaffolding, the scaffolding configured to define a substantially cylindrical member having a proximal end and a distal end having a internal diameter larger than that of the proximal end and the substantially cylindrical member extending longitudinally there between and defining a plurality of eyelets along the longitudinal expanse thereof and suture threaded there through, the scaffolding forming a lumen there through, such that when pressure is exerted along varying points of the longitudinal extension of the appliance, the appliance does not undesirably foreshorten or elongate;
grasping the suture threaded through the eyelets of the medical appliance;
pulling on the suture to reduce the outward radial force of the medical appliance; and removing the medical appliance from the patient.
locating the medical appliance comprising a scaffolding, the scaffolding configured to define a substantially cylindrical member having a proximal end and a distal end having a internal diameter larger than that of the proximal end and the substantially cylindrical member extending longitudinally there between and defining a plurality of eyelets along the longitudinal expanse thereof and suture threaded there through, the scaffolding forming a lumen there through, such that when pressure is exerted along varying points of the longitudinal extension of the appliance, the appliance does not undesirably foreshorten or elongate;
grasping the suture threaded through the eyelets of the medical appliance;
pulling on the suture to reduce the outward radial force of the medical appliance; and removing the medical appliance from the patient.
50. An article of manufacture for placement in the intestinal system of a patient wherein said patient has had the Sphincter of Oddi rendered inoperable, the article comprising an annular ring for placement about the location of the Sphincter of Oddi to prevent the reocclusion of the intestinal tract.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/674,972 | 2003-09-30 | ||
US10/674,972 US7875068B2 (en) | 2002-11-05 | 2003-09-30 | Removable biliary stent |
PCT/US2004/031906 WO2005032415A2 (en) | 2003-09-30 | 2004-09-29 | Removable biliary stent |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2540676A1 true CA2540676A1 (en) | 2005-04-14 |
Family
ID=34422078
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002540676A Abandoned CA2540676A1 (en) | 2003-09-30 | 2004-09-29 | Removable biliary stent |
Country Status (6)
Country | Link |
---|---|
US (1) | US7875068B2 (en) |
EP (1) | EP1684680A4 (en) |
JP (1) | JP2007532145A (en) |
AU (1) | AU2004277973A1 (en) |
CA (1) | CA2540676A1 (en) |
WO (1) | WO2005032415A2 (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040236414A1 (en) * | 2003-05-23 | 2004-11-25 | Brar Balbir S. | Devices and methods for treatment of stenotic regions |
US7226473B2 (en) * | 2003-05-23 | 2007-06-05 | Brar Balbir S | Treatment of stenotic regions |
US7914569B2 (en) | 2005-05-13 | 2011-03-29 | Medtronics Corevalve Llc | Heart valve prosthesis and methods of manufacture and use |
US20070021840A1 (en) * | 2005-07-20 | 2007-01-25 | Jorge Lopera | Temporal stricture expander |
AU2007349205B2 (en) * | 2006-10-16 | 2013-05-23 | Cook Medical Technologies Llc | Nonexpandable stent |
US20080300671A1 (en) * | 2007-06-04 | 2008-12-04 | Gil Vardi | Stent having high expansion ratio |
AT506842B1 (en) * | 2008-06-12 | 2010-03-15 | Michaela Dr Abrahamowicz | DEVICE FOR DIAGNOSIS OF AN INNER RECTANGULAR PROLAPSE AND SURFACE SOIL REDUCTION AND FOR DETERMINING DOUGLAS DEPTH |
US8114149B2 (en) * | 2009-10-20 | 2012-02-14 | Svelte Medical Systems, Inc. | Hybrid stent with helical connectors |
USD660967S1 (en) * | 2010-09-20 | 2012-05-29 | St. Jude Medical, Inc. | Surgical stent |
USD684692S1 (en) | 2010-09-20 | 2013-06-18 | St. Jude Medical, Inc. | Forked ends |
USD654170S1 (en) * | 2010-09-20 | 2012-02-14 | St. Jude Medical, Inc. | Stent connections |
USD654169S1 (en) | 2010-09-20 | 2012-02-14 | St. Jude Medical Inc. | Forked ends |
USD648854S1 (en) | 2010-09-20 | 2011-11-15 | St. Jude Medical, Inc. | Commissure points |
USD652926S1 (en) | 2010-09-20 | 2012-01-24 | St. Jude Medical, Inc. | Forked end |
USD660432S1 (en) | 2010-09-20 | 2012-05-22 | St. Jude Medical, Inc. | Commissure point |
USD653341S1 (en) * | 2010-09-20 | 2012-01-31 | St. Jude Medical, Inc. | Surgical stent |
USD660433S1 (en) * | 2010-09-20 | 2012-05-22 | St. Jude Medical, Inc. | Surgical stent assembly |
USD652927S1 (en) * | 2010-09-20 | 2012-01-24 | St. Jude Medical, Inc. | Surgical stent |
USD653343S1 (en) | 2010-09-20 | 2012-01-31 | St. Jude Medical, Inc. | Surgical cuff |
USD653342S1 (en) | 2010-09-20 | 2012-01-31 | St. Jude Medical, Inc. | Stent connections |
US20130018215A1 (en) * | 2011-01-18 | 2013-01-17 | Merit Medical Systems, Inc. | Esophageal stent and methods for use of same |
US10285798B2 (en) * | 2011-06-03 | 2019-05-14 | Merit Medical Systems, Inc. | Esophageal stent |
US8986368B2 (en) | 2011-10-31 | 2015-03-24 | Merit Medical Systems, Inc. | Esophageal stent with valve |
US9687367B2 (en) * | 2012-06-05 | 2017-06-27 | Merit Medical Systems, Inc. | Esophageal stent |
ES2901800T3 (en) | 2013-02-28 | 2022-03-23 | Boston Scient Scimed Inc | Medical devices for use in the biliary and/or pancreatic tract |
CA2891225C (en) | 2013-03-05 | 2021-03-02 | Merit Medical Systems, Inc. | Reinforced valve |
US9415196B2 (en) | 2013-03-13 | 2016-08-16 | Boston Scientific Scimed, Inc. | Pancreatic stent drainage system |
US9623220B2 (en) * | 2013-03-14 | 2017-04-18 | The Alfred E. Mann Foundation For Scientific Research | Suture tracking dilators and related methods |
EP2967927A4 (en) | 2013-03-15 | 2016-10-12 | Merit Medical Systems Inc | Esophageal stent |
USD730520S1 (en) | 2013-09-04 | 2015-05-26 | St. Jude Medical, Cardiology Division, Inc. | Stent with commissure attachments |
USD730521S1 (en) | 2013-09-04 | 2015-05-26 | St. Jude Medical, Cardiology Division, Inc. | Stent with commissure attachments |
JP6197122B2 (en) | 2013-09-12 | 2017-09-13 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | Stent with deviance connector |
ES2678047T3 (en) | 2014-03-18 | 2018-08-08 | Boston Scientific Scimed, Inc. | Stent design to reduce granulation and inflammation |
US20150282922A1 (en) * | 2014-04-08 | 2015-10-08 | Boston Scientific Scimed Inc. | Partially coated stents |
US10219921B2 (en) | 2014-10-02 | 2019-03-05 | Boston Scientific Scimed, Inc. | Controlled ingrowth feature for antimigration |
WO2016065086A1 (en) | 2014-10-22 | 2016-04-28 | Boston Scientific Scimed, Inc. | Stent with flexible hinge |
WO2016073597A1 (en) | 2014-11-06 | 2016-05-12 | Boston Scientific Scimed, Inc. | Tracheal stent |
CN110037827B (en) | 2015-01-16 | 2021-11-30 | 波士顿科学国际有限公司 | Implantable medical device with reduced migration capability |
DE102015108835A1 (en) * | 2015-06-03 | 2016-12-08 | Andratec Gmbh | vessel support |
US10426592B2 (en) | 2016-04-11 | 2019-10-01 | Boston Scientific Scimed, Inc. | Implantable medical device with reduced migration capabilities |
US10744009B2 (en) | 2017-03-15 | 2020-08-18 | Merit Medical Systems, Inc. | Transluminal stents and related methods |
CN108186175A (en) * | 2018-02-02 | 2018-06-22 | 青岛市中心医院 | A kind of novel and multifunctional Internal Medicine-Cardiovascular Dept. coronary artery bracket |
CN112469371A (en) | 2018-07-29 | 2021-03-09 | Bvw控股公司 | Biliary tract stent |
JP7348292B2 (en) | 2019-01-07 | 2023-09-20 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Stent with anti-migration mechanism |
WO2021146021A1 (en) | 2020-01-13 | 2021-07-22 | Boston Scientific Scimed, Inc. | Anti-migration stent |
EP4099961A1 (en) | 2020-02-03 | 2022-12-14 | Boston Scientific Scimed, Inc. | Stent, mandrel, and method for forming a stent with anti-migration features |
AU2021390484A1 (en) | 2020-12-02 | 2023-06-22 | Boston Scientific Scimed, Inc. | Stent with improved deployment characteristics |
Family Cites Families (398)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3818511A (en) | 1972-11-17 | 1974-06-25 | Medical Prod Corp | Medical prosthesis for ducts or conduits |
GB2056023B (en) | 1979-08-06 | 1983-08-10 | Ross D N Bodnar E | Stent for a cardiac valve |
US4441215A (en) | 1980-11-17 | 1984-04-10 | Kaster Robert L | Vascular graft |
SE445884B (en) | 1982-04-30 | 1986-07-28 | Medinvent Sa | DEVICE FOR IMPLANTATION OF A RODFORM PROTECTION |
US4680031A (en) | 1982-11-29 | 1987-07-14 | Tascon Medical Technology Corporation | Heart valve prosthesis |
US5688254A (en) | 1983-01-24 | 1997-11-18 | Icu Medical, Inc. | Medical connector |
US5067957A (en) | 1983-10-14 | 1991-11-26 | Raychem Corporation | Method of inserting medical devices incorporating SIM alloy elements |
US5190546A (en) | 1983-10-14 | 1993-03-02 | Raychem Corporation | Medical devices incorporating SIM alloy elements |
US4665906A (en) | 1983-10-14 | 1987-05-19 | Raychem Corporation | Medical devices incorporating sim alloy elements |
FR2556210B1 (en) | 1983-12-08 | 1988-04-15 | Barra Jean Aubert | VENOUS PROSTHESIS AND PROCESS FOR PRODUCING THE SAME |
JPS6198254A (en) | 1984-10-19 | 1986-05-16 | ザ・ベントリー―ハリス・マニュファクチュアリング・カンパニー | Prosthetic stent |
US5102417A (en) | 1985-11-07 | 1992-04-07 | Expandable Grafts Partnership | Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft |
US4733665C2 (en) | 1985-11-07 | 2002-01-29 | Expandable Grafts Partnership | Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft |
US4820262A (en) | 1985-12-12 | 1989-04-11 | Medical Engineering Corporation | Ureteral stent |
SE453258B (en) | 1986-04-21 | 1988-01-25 | Medinvent Sa | ELASTIC, SELF-EXPANDING PROTEST AND PROCEDURE FOR ITS MANUFACTURING |
US4800882A (en) | 1987-03-13 | 1989-01-31 | Cook Incorporated | Endovascular stent and delivery system |
US4886062A (en) | 1987-10-19 | 1989-12-12 | Medtronic, Inc. | Intravascular radially expandable stent and method of implant |
US4820298A (en) | 1987-11-20 | 1989-04-11 | Leveen Eric G | Internal vascular prosthesis |
US5032128A (en) | 1988-07-07 | 1991-07-16 | Medtronic, Inc. | Heart valve prosthesis |
CA1322628C (en) | 1988-10-04 | 1993-10-05 | Richard A. Schatz | Expandable intraluminal graft |
US4856516A (en) | 1989-01-09 | 1989-08-15 | Cordis Corporation | Endovascular stent apparatus and method |
US5364340A (en) | 1989-01-25 | 1994-11-15 | Coll Milton E | Ureteral stent-catheter having varying internal diameter and method of use |
US5292331A (en) | 1989-08-24 | 1994-03-08 | Applied Vascular Engineering, Inc. | Endovascular support device |
CA2026604A1 (en) | 1989-10-02 | 1991-04-03 | Rodney G. Wolff | Articulated stent |
US5229431A (en) | 1990-06-15 | 1993-07-20 | Corvita Corporation | Crack-resistant polycarbonate urethane polymer prostheses and the like |
US5064435A (en) | 1990-06-28 | 1991-11-12 | Schneider (Usa) Inc. | Self-expanding prosthesis having stable axial length |
US5356423A (en) | 1991-01-04 | 1994-10-18 | American Medical Systems, Inc. | Resectable self-expanding stent |
US5073694A (en) | 1991-02-21 | 1991-12-17 | Synthes (U.S.A.) | Method and apparatus for laser cutting a hollow metal workpiece |
US5383925A (en) | 1992-09-14 | 1995-01-24 | Meadox Medicals, Inc. | Three-dimensional braided soft tissue prosthesis |
DE4122923C1 (en) | 1991-07-11 | 1993-01-28 | Willy Ruesch Ag, 7053 Kernen, De | |
US5443498A (en) | 1991-10-01 | 1995-08-22 | Cook Incorporated | Vascular stent and method of making and implanting a vacsular stent |
US5876445A (en) | 1991-10-09 | 1999-03-02 | Boston Scientific Corporation | Medical stents for body lumens exhibiting peristaltic motion |
US5662713A (en) | 1991-10-09 | 1997-09-02 | Boston Scientific Corporation | Medical stents for body lumens exhibiting peristaltic motion |
EP0536610B1 (en) | 1991-10-11 | 1997-09-03 | Angiomed GmbH & Co. Medizintechnik KG | Stenosis dilatation device |
US5354309A (en) | 1991-10-11 | 1994-10-11 | Angiomed Ag | Apparatus for widening a stenosis in a body cavity |
CA2380683C (en) | 1991-10-28 | 2006-08-08 | Advanced Cardiovascular Systems, Inc. | Expandable stents and method for making same |
FR2683449A1 (en) | 1991-11-08 | 1993-05-14 | Cardon Alain | ENDOPROTHESIS FOR TRANSLUMINAL IMPLANTATION. |
US5683448A (en) | 1992-02-21 | 1997-11-04 | Boston Scientific Technology, Inc. | Intraluminal stent and graft |
US5817102A (en) | 1992-05-08 | 1998-10-06 | Schneider (Usa) Inc. | Apparatus for delivering and deploying a stent |
WO1993022986A1 (en) | 1992-05-08 | 1993-11-25 | Schneider (Usa) Inc. | Esophageal stent and delivery tool |
DE4220295A1 (en) | 1992-06-20 | 1993-12-23 | Angiomed Ag | Device for correcting the position of a stent |
US6336938B1 (en) | 1992-08-06 | 2002-01-08 | William Cook Europe A/S | Implantable self expanding prosthetic device |
US5562725A (en) | 1992-09-14 | 1996-10-08 | Meadox Medicals Inc. | Radially self-expanding implantable intraluminal device |
CA2149887A1 (en) | 1992-12-30 | 1994-07-21 | Steven J. Healy | Apparatus for deploying body implantable stents |
DE4303181A1 (en) | 1993-02-04 | 1994-08-11 | Angiomed Ag | Implantable catheter |
DK0703761T3 (en) | 1993-03-11 | 2003-05-26 | Medinol Ltd | Stent |
US5345057A (en) | 1993-03-25 | 1994-09-06 | Lasag Ag | Method of cutting an aperture in a device by means of a laser beam |
ES2114964T3 (en) | 1993-04-23 | 1998-06-16 | Schneider Europ Ag | ENDOPROTESIS WITH A COAT OF ELASTIC MATERIAL COATING AND METHOD FOR APPLYING THE COAT ON ENDOPROTESIS. |
SE505436C2 (en) | 1993-04-27 | 1997-08-25 | Ams Medinvent Sa | prostatic stent |
US6689158B1 (en) | 1993-09-30 | 2004-02-10 | Endogad Research Pty Limited | Intraluminal graft |
DE4334140C2 (en) | 1993-10-07 | 1996-04-18 | Angiomed Ag | Stent and device with stent |
RU2089131C1 (en) | 1993-12-28 | 1997-09-10 | Сергей Апполонович Пульнев | Stent-expander |
US5876418A (en) | 1994-01-13 | 1999-03-02 | Angiomed Ag | Device for providing a duct in a living body |
DE69514690T3 (en) | 1994-02-25 | 2006-09-14 | Fischell, Robert E. | stent |
US5643312A (en) | 1994-02-25 | 1997-07-01 | Fischell Robert | Stent having a multiplicity of closed circular structures |
US6461381B2 (en) | 1994-03-17 | 2002-10-08 | Medinol, Ltd. | Flexible expandable stent |
US5843120A (en) | 1994-03-17 | 1998-12-01 | Medinol Ltd. | Flexible-expandable stent |
US5733303A (en) | 1994-03-17 | 1998-03-31 | Medinol Ltd. | Flexible expandable stent |
US5449373A (en) | 1994-03-17 | 1995-09-12 | Medinol Ltd. | Articulated stent |
US6464722B2 (en) | 1994-03-17 | 2002-10-15 | Medinol, Ltd. | Flexible expandable stent |
JP2825452B2 (en) | 1994-04-25 | 1998-11-18 | アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド | Radiopak stent marker |
DE4418336A1 (en) | 1994-05-26 | 1995-11-30 | Angiomed Ag | Stent for widening and holding open receptacles |
DE29522101U1 (en) | 1994-06-08 | 1999-12-09 | Cardiovascular Concepts Inc | Endoluminal prosthesis |
US6736843B1 (en) | 1994-07-25 | 2004-05-18 | Advanced Cardiovascular Systems, Inc. | Cylindrically-shaped balloon-expandable stent |
US5591157A (en) | 1994-09-07 | 1997-01-07 | Hennings; David R. | Method and apparatus for tympanic membrane shrinkage |
US6746482B2 (en) | 1994-10-17 | 2004-06-08 | Baxter International Inc. | Method for producing medical devices and devices so produced |
US5836964A (en) | 1996-10-30 | 1998-11-17 | Medinol Ltd. | Stent fabrication method |
CA2201128C (en) | 1994-10-27 | 2000-10-24 | Jeffrey A. Helgerson | Stent delivery device |
CA2163824C (en) | 1994-11-28 | 2000-06-20 | Richard J. Saunders | Method and apparatus for direct laser cutting of metal stents |
DE4446036C2 (en) | 1994-12-23 | 1999-06-02 | Ruesch Willy Ag | Placeholder for placement in a body tube |
US5575818A (en) | 1995-02-14 | 1996-11-19 | Corvita Corporation | Endovascular stent with locking ring |
EP0810845A2 (en) | 1995-02-22 | 1997-12-10 | Menlo Care Inc. | Covered expanding mesh stent |
US6896696B2 (en) | 1998-11-20 | 2005-05-24 | Scimed Life Systems, Inc. | Flexible and expandable stent |
US6818014B2 (en) | 1995-03-01 | 2004-11-16 | Scimed Life Systems, Inc. | Longitudinally flexible expandable stent |
DE69622231T2 (en) | 1995-03-01 | 2002-12-05 | Scimed Life Systems Inc | LENGTHFLEXIBLE AND EXPANDABLE STENT |
US7204848B1 (en) | 1995-03-01 | 2007-04-17 | Boston Scientific Scimed, Inc. | Longitudinally flexible expandable stent |
DE19508805C2 (en) | 1995-03-06 | 2000-03-30 | Lutz Freitag | Stent for placement in a body tube with a flexible support structure made of at least two wires with different shape memory functions |
US5556414A (en) | 1995-03-08 | 1996-09-17 | Wayne State University | Composite intraluminal graft |
US6579314B1 (en) | 1995-03-10 | 2003-06-17 | C.R. Bard, Inc. | Covered stent with encapsulated ends |
US6451047B2 (en) | 1995-03-10 | 2002-09-17 | Impra, Inc. | Encapsulated intraluminal stent-graft and methods of making same |
US5591197A (en) | 1995-03-14 | 1997-01-07 | Advanced Cardiovascular Systems, Inc. | Expandable stent forming projecting barbs and method for deploying |
ES2119527T5 (en) | 1995-04-01 | 2006-11-16 | Variomed Ag | STENT DEVICE FOR TRANSLUMINAL IMPLEMENTATION IN HOLLOW ORGANS. |
BE1009278A3 (en) | 1995-04-12 | 1997-01-07 | Corvita Europ | Guardian self-expandable medical device introduced in cavite body, and medical device with a stake as. |
US5837313A (en) | 1995-04-19 | 1998-11-17 | Schneider (Usa) Inc | Drug release stent coating process |
US5593442A (en) | 1995-06-05 | 1997-01-14 | Localmed, Inc. | Radially expansible and articulated vessel scaffold |
CA2178541C (en) | 1995-06-07 | 2009-11-24 | Neal E. Fearnot | Implantable medical device |
US6774278B1 (en) | 1995-06-07 | 2004-08-10 | Cook Incorporated | Coated implantable medical device |
US5609629A (en) | 1995-06-07 | 1997-03-11 | Med Institute, Inc. | Coated implantable medical device |
US5833707A (en) | 1995-07-05 | 1998-11-10 | Advanced Cardiovascular Systems, Inc. | Removable stent and method of deployment |
US5769882A (en) | 1995-09-08 | 1998-06-23 | Medtronic, Inc. | Methods and apparatus for conformably sealing prostheses within body lumens |
US5702418A (en) | 1995-09-12 | 1997-12-30 | Boston Scientific Corporation | Stent delivery system |
US6689162B1 (en) | 1995-10-11 | 2004-02-10 | Boston Scientific Scimed, Inc. | Braided composite prosthesis |
US5776161A (en) | 1995-10-16 | 1998-07-07 | Instent, Inc. | Medical stents, apparatus and method for making same |
US5628788A (en) | 1995-11-07 | 1997-05-13 | Corvita Corporation | Self-expanding endoluminal stent-graft |
DE69526857T2 (en) | 1995-11-27 | 2003-01-02 | Schneider Europ Gmbh Buelach | Stent for use in one pass |
US6719782B1 (en) | 1996-01-04 | 2004-04-13 | Endovascular Technologies, Inc. | Flat wire stent |
US5938682A (en) | 1996-01-26 | 1999-08-17 | Cordis Corporation | Axially flexible stent |
IL125417A (en) | 1996-02-02 | 2004-03-28 | Transvascular Inc | Apparatus for blocking flow through blood vessels |
CA2192520A1 (en) | 1996-03-05 | 1997-09-05 | Ian M. Penn | Expandable stent and method for delivery of same |
US6796997B1 (en) | 1996-03-05 | 2004-09-28 | Evysio Medical Devices Ulc | Expandable stent |
EP1477133B9 (en) | 1996-03-05 | 2007-11-21 | Evysio Medical Devices Ulc | Expandable stent |
CA2199890C (en) | 1996-03-26 | 2002-02-05 | Leonard Pinchuk | Stents and stent-grafts having enhanced hoop strength and methods of making the same |
US6533805B1 (en) | 1996-04-01 | 2003-03-18 | General Surgical Innovations, Inc. | Prosthesis and method for deployment within a body lumen |
US5824042A (en) | 1996-04-05 | 1998-10-20 | Medtronic, Inc. | Endoluminal prostheses having position indicating markers |
US5713949A (en) | 1996-08-06 | 1998-02-03 | Jayaraman; Swaminathan | Microporous covered stents and method of coating |
JP4636634B2 (en) | 1996-04-26 | 2011-02-23 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Intravascular stent |
US6241760B1 (en) | 1996-04-26 | 2001-06-05 | G. David Jang | Intravascular stent |
US6251133B1 (en) | 1996-05-03 | 2001-06-26 | Medinol Ltd. | Bifurcated stent with improved side branch aperture and method of making same |
UA58485C2 (en) | 1996-05-03 | 2003-08-15 | Медінол Лтд. | Method for manufacture of bifurcated stent (variants) and bifurcated stent (variants) |
US5800514A (en) | 1996-05-24 | 1998-09-01 | Meadox Medicals, Inc. | Shaped woven tubular soft-tissue prostheses and methods of manufacturing |
BR9702255A (en) | 1996-05-31 | 1999-02-17 | Bard Galway Ltd | Bifurcated endovascular extenders and methods and apparatus for placing them |
US8728143B2 (en) | 1996-06-06 | 2014-05-20 | Biosensors International Group, Ltd. | Endoprosthesis deployment system for treating vascular bifurcations |
US5697971A (en) | 1996-06-11 | 1997-12-16 | Fischell; Robert E. | Multi-cell stent with cells having differing characteristics |
US5922020A (en) | 1996-08-02 | 1999-07-13 | Localmed, Inc. | Tubular prosthesis having improved expansion and imaging characteristics |
US5755781A (en) | 1996-08-06 | 1998-05-26 | Iowa-India Investments Company Limited | Embodiments of multiple interconnected stents |
US6174329B1 (en) | 1996-08-22 | 2001-01-16 | Advanced Cardiovascular Systems, Inc. | Protective coating for a stent with intermediate radiopaque coating |
US5797887A (en) | 1996-08-27 | 1998-08-25 | Novovasc Llc | Medical device with a surface adapted for exposure to a blood stream which is coated with a polymer containing a nitrosyl-containing organo-metallic compound which releases nitric oxide from the coating to mediate platelet aggregation |
US5807404A (en) | 1996-09-19 | 1998-09-15 | Medinol Ltd. | Stent with variable features to optimize support and method of making such stent |
US6451044B1 (en) | 1996-09-20 | 2002-09-17 | Board Of Regents, The University Of Texas System | Method and apparatus for heating inflammed tissue |
EP0934035B8 (en) | 1996-09-26 | 2006-01-18 | Boston Scientific Scimed, Inc. | Support structure/membrane composite medical device |
US5755776A (en) | 1996-10-04 | 1998-05-26 | Al-Saadon; Khalid | Permanent expandable intraluminal tubular stent |
US5868781A (en) | 1996-10-22 | 1999-02-09 | Scimed Life Systems, Inc. | Locking stent |
US6692483B2 (en) | 1996-11-04 | 2004-02-17 | Advanced Stent Technologies, Inc. | Catheter with attached flexible side sheath |
US6325826B1 (en) | 1998-01-14 | 2001-12-04 | Advanced Stent Technologies, Inc. | Extendible stent apparatus |
WO1998020810A1 (en) | 1996-11-12 | 1998-05-22 | Medtronic, Inc. | Flexible, radially expansible luminal prostheses |
US6027527A (en) | 1996-12-06 | 2000-02-22 | Piolax Inc. | Stent |
CA2274906A1 (en) | 1996-12-13 | 1998-06-18 | Gregory J. Delmain | Biocompatible medical devices with polyurethane surface |
US5868782A (en) | 1996-12-24 | 1999-02-09 | Global Therapeutics, Inc. | Radially expandable axially non-contracting surgical stent |
US5906759A (en) | 1996-12-26 | 1999-05-25 | Medinol Ltd. | Stent forming apparatus with stent deforming blades |
IT1289815B1 (en) | 1996-12-30 | 1998-10-16 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT AND RELATED PRODUCTION PROCESS |
FR2758253B1 (en) | 1997-01-10 | 1999-04-02 | Nycomed Lab Sa | IMPLANTABLE DEVICE FOR THE TREATMENT OF A BODY DUCT |
US5827321A (en) * | 1997-02-07 | 1998-10-27 | Cornerstone Devices, Inc. | Non-Foreshortening intraluminal prosthesis |
FR2760351B1 (en) | 1997-03-04 | 1999-05-28 | Bernard Glatt | HELICAL STENT FORMING DEVICE AND MANUFACTURING METHOD THEREOF |
EP1011529B1 (en) | 1997-03-05 | 2005-01-26 | Boston Scientific Limited | Conformal laminate stent device |
US5911732A (en) | 1997-03-10 | 1999-06-15 | Johnson & Johnson Interventional Systems, Co. | Articulated expandable intraluminal stent |
US5853419A (en) | 1997-03-17 | 1998-12-29 | Surface Genesis, Inc. | Stent |
US6096071A (en) | 1998-03-26 | 2000-08-01 | Yadav; Jay S. | Ostial stent |
US5902475A (en) | 1997-04-08 | 1999-05-11 | Interventional Technologies, Inc. | Method for manufacturing a stent |
US6240616B1 (en) | 1997-04-15 | 2001-06-05 | Advanced Cardiovascular Systems, Inc. | Method of manufacturing a medicated porous metal prosthesis |
US6776792B1 (en) | 1997-04-24 | 2004-08-17 | Advanced Cardiovascular Systems Inc. | Coated endovascular stent |
US6033433A (en) | 1997-04-25 | 2000-03-07 | Scimed Life Systems, Inc. | Stent configurations including spirals |
US6451049B2 (en) | 1998-04-29 | 2002-09-17 | Sorin Biomedica Cardio, S.P.A. | Stents for angioplasty |
IT1292295B1 (en) | 1997-04-29 | 1999-01-29 | Sorin Biomedica Cardio Spa | ANGIOPLASTIC STENT |
DE19718339A1 (en) | 1997-04-30 | 1998-11-12 | Schering Ag | Polymer coated stents, processes for their manufacture and their use for restenosis prophylaxis |
US5957929A (en) | 1997-05-02 | 1999-09-28 | Micro Therapeutics, Inc. | Expandable stent apparatus and method |
US5741327A (en) | 1997-05-06 | 1998-04-21 | Global Therapeutics, Inc. | Surgical stent featuring radiopaque markers |
DE29708803U1 (en) | 1997-05-17 | 1997-07-31 | Jomed Implantate Gmbh | Radially expandable stent for implantation in a body vessel in the area of a vascular branch |
DE29708879U1 (en) | 1997-05-20 | 1997-07-31 | Jomed Implantate Gmbh | Coronary stent |
US5836966A (en) | 1997-05-22 | 1998-11-17 | Scimed Life Systems, Inc. | Variable expansion force stent |
CA2235911C (en) | 1997-05-27 | 2003-07-29 | Schneider (Usa) Inc. | Stent and stent-graft for treating branched vessels |
BE1011180A6 (en) | 1997-05-27 | 1999-06-01 | Medicorp R & D Benelux Sa | Luminal endoprosthesis AUTO EXPANDABLE. |
EP0884029B1 (en) | 1997-06-13 | 2004-12-22 | Gary J. Becker | Expandable intraluminal endoprosthesis |
US6203536B1 (en) | 1997-06-17 | 2001-03-20 | Medtronic, Inc. | Medical device for delivering a therapeutic substance and method therefor |
US6723121B1 (en) | 1997-06-18 | 2004-04-20 | Scimed Life Systems, Inc. | Polycarbonate-polyurethane dispersions for thrombo-resistant coatings |
US6165195A (en) | 1997-08-13 | 2000-12-26 | Advanced Cardiovascylar Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6316522B1 (en) | 1997-08-18 | 2001-11-13 | Scimed Life Systems, Inc. | Bioresorbable hydrogel compositions for implantable prostheses |
US6746476B1 (en) | 1997-09-22 | 2004-06-08 | Cordis Corporation | Bifurcated axially flexible stent |
ES2290995T3 (en) | 1997-09-24 | 2008-02-16 | Med Institute, Inc. | RADIALLY EXPANDABLE ENDOPROTESIS. |
US6071308A (en) | 1997-10-01 | 2000-06-06 | Boston Scientific Corporation | Flexible metal wire stent |
US6013091A (en) | 1997-10-09 | 2000-01-11 | Scimed Life Systems, Inc. | Stent configurations |
DE19746882A1 (en) | 1997-10-23 | 1999-04-29 | Angiomed Ag | Expandable stent for tubular anatomical structures such as bile-ducts |
US6120534A (en) | 1997-10-29 | 2000-09-19 | Ruiz; Carlos E. | Endoluminal prosthesis having adjustable constriction |
US6033435A (en) | 1997-11-03 | 2000-03-07 | Divysio Solutions Ulc | Bifurcated stent and method for the manufacture and delivery of same |
US6309414B1 (en) | 1997-11-04 | 2001-10-30 | Sorin Biomedica Cardio S.P.A. | Angioplasty stents |
NO311781B1 (en) | 1997-11-13 | 2002-01-28 | Medinol Ltd | Metal multilayer stents |
US6330884B1 (en) | 1997-11-14 | 2001-12-18 | Transvascular, Inc. | Deformable scaffolding multicellular stent |
US6267782B1 (en) | 1997-11-20 | 2001-07-31 | St. Jude Medical, Inc. | Medical article with adhered antimicrobial metal |
DE19754747A1 (en) | 1997-12-10 | 1999-06-17 | Impag Gmbh Medizintechnik | Device for being implanted into hollow space of human body in particular into gullet |
US6179867B1 (en) | 1998-01-16 | 2001-01-30 | Advanced Cardiovascular Systems, Inc. | Flexible stent and method of use |
EP0945107A3 (en) | 1998-01-23 | 2000-01-19 | Arterial Vascular Engineering, Inc. | Helical stent |
US6533807B2 (en) | 1998-02-05 | 2003-03-18 | Medtronic, Inc. | Radially-expandable stent and delivery system |
US6115418A (en) * | 1998-02-09 | 2000-09-05 | National Semiconductor Corporation | Simplified equalizer for twisted pair channel |
WO1999040876A2 (en) * | 1998-02-17 | 1999-08-19 | Jang G David | Tubular stent consists of chevron-shape expansion struts and ipsilaterally attached m-frame connectors |
US5931866A (en) | 1998-02-24 | 1999-08-03 | Frantzen; John J. | Radially expandable stent featuring accordion stops |
US6488701B1 (en) | 1998-03-31 | 2002-12-03 | Medtronic Ave, Inc. | Stent-graft assembly with thin-walled graft component and method of manufacture |
US6099650A (en) | 1998-03-03 | 2000-08-08 | Concept Systems Design, Inc. | Structure and method for reducing slip in semiconductor wafers |
US5938697A (en) | 1998-03-04 | 1999-08-17 | Scimed Life Systems, Inc. | Stent having variable properties |
ATE471132T1 (en) | 1998-03-04 | 2010-07-15 | Boston Scient Ltd | STENT WITH IMPROVED CELL CONFIGURATION |
AU2891899A (en) | 1998-03-05 | 1999-09-20 | Boston Scientific Limited | Intraluminal stent |
US6019778A (en) | 1998-03-13 | 2000-02-01 | Cordis Corporation | Delivery apparatus for a self-expanding stent |
US5935162A (en) | 1998-03-16 | 1999-08-10 | Medtronic, Inc. | Wire-tubular hybrid stent |
US6132461A (en) | 1998-03-27 | 2000-10-17 | Intratherapeutics, Inc. | Stent with dual support structure |
BR9909102A (en) | 1998-04-02 | 2000-12-05 | Salviac Ltd | Medical catheter, method for its preparation, wrapping for it, and delivery system for transvascular deployment of a medical device |
US6436133B1 (en) | 1998-04-15 | 2002-08-20 | Joseph G. Furst | Expandable graft |
US6206916B1 (en) | 1998-04-15 | 2001-03-27 | Joseph G. Furst | Coated intraluminal graft |
JP4583597B2 (en) | 1998-05-05 | 2010-11-17 | ボストン サイエンティフィック リミテッド | Smooth end stent |
DE19822157B4 (en) | 1998-05-16 | 2013-01-10 | Abbott Laboratories Vascular Enterprises Ltd. | Radially expandable stent for implantation in a body vessel |
US6740113B2 (en) | 1998-05-29 | 2004-05-25 | Scimed Life Systems, Inc. | Balloon expandable stent with a self-expanding portion |
EP1082072B8 (en) | 1998-06-04 | 2014-03-05 | New York University | Endovascular thin film devices for treating and preventing stroke |
US6171334B1 (en) | 1998-06-17 | 2001-01-09 | Advanced Cardiovascular Systems, Inc. | Expandable stent and method of use |
US6461380B1 (en) | 1998-07-28 | 2002-10-08 | Advanced Cardiovascular Systems, Inc. | Stent configuration |
US6159239A (en) | 1998-08-14 | 2000-12-12 | Prodesco, Inc. | Woven stent/graft structure |
AU771367B2 (en) | 1998-08-20 | 2004-03-18 | Cook Medical Technologies Llc | Coated implantable medical device |
DE19839646A1 (en) | 1998-08-31 | 2000-03-09 | Jomed Implantate Gmbh | Stent |
DE19840645A1 (en) | 1998-09-05 | 2000-03-09 | Jomed Implantate Gmbh | Stent |
US6682554B2 (en) | 1998-09-05 | 2004-01-27 | Jomed Gmbh | Methods and apparatus for a stent having an expandable web structure |
US6755856B2 (en) | 1998-09-05 | 2004-06-29 | Abbott Laboratories Vascular Enterprises Limited | Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation |
US6193744B1 (en) | 1998-09-10 | 2001-02-27 | Scimed Life Systems, Inc. | Stent configurations |
US6432126B1 (en) | 1998-09-30 | 2002-08-13 | C.R. Bard, Inc. | Flexible vascular inducing implants |
US6547814B2 (en) | 1998-09-30 | 2003-04-15 | Impra, Inc. | Selective adherence of stent-graft coverings |
US6273909B1 (en) | 1998-10-05 | 2001-08-14 | Teramed Inc. | Endovascular graft system |
US6042597A (en) | 1998-10-23 | 2000-03-28 | Scimed Life Systems, Inc. | Helical stent design |
US6475234B1 (en) | 1998-10-26 | 2002-11-05 | Medinol, Ltd. | Balloon expandable covered stents |
WO2000027463A1 (en) | 1998-11-11 | 2000-05-18 | Mark Wilson Ian Webster | Bifurcation stent and delivery systems |
US6660030B2 (en) | 1998-12-11 | 2003-12-09 | Endologix, Inc. | Bifurcation graft deployment catheter |
US6733523B2 (en) | 1998-12-11 | 2004-05-11 | Endologix, Inc. | Implantable vascular graft |
EP1146833B1 (en) | 1998-12-11 | 2005-08-31 | Endologix, Inc. | Endoluminal vascular prosthesis |
US6238335B1 (en) | 1998-12-11 | 2001-05-29 | Enteric Medical Technologies, Inc. | Method for treating gastroesophageal reflux disease and apparatus for use therewith |
US6383204B1 (en) | 1998-12-15 | 2002-05-07 | Micrus Corporation | Variable stiffness coil for vasoocclusive devices |
US6743252B1 (en) | 1998-12-18 | 2004-06-01 | Cook Incorporated | Cannula stent |
US6530950B1 (en) | 1999-01-12 | 2003-03-11 | Quanam Medical Corporation | Intraluminal stent having coaxial polymer member |
WO2000042949A2 (en) | 1999-01-22 | 2000-07-27 | Gore Enterprise Holdings, Inc. | A biliary stent-graft |
US6673102B1 (en) | 1999-01-22 | 2004-01-06 | Gore Enterprises Holdings, Inc. | Covered endoprosthesis and delivery system |
DK1148839T3 (en) | 1999-02-01 | 2008-12-15 | Univ Texas | Woven two-branched and three-branched stents and methods of making them |
US6361557B1 (en) | 1999-02-05 | 2002-03-26 | Medtronic Ave, Inc. | Staplebutton radiopaque marker |
US6695876B1 (en) | 1999-02-12 | 2004-02-24 | Thomas R. Marotta | Endovascular prosthesis |
US6248122B1 (en) | 1999-02-26 | 2001-06-19 | Vascular Architects, Inc. | Catheter with controlled release endoluminal prosthesis |
US6251134B1 (en) * | 1999-02-28 | 2001-06-26 | Inflow Dynamics Inc. | Stent with high longitudinal flexibility |
US6273910B1 (en) | 1999-03-11 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Stent with varying strut geometry |
US6620192B1 (en) | 1999-03-16 | 2003-09-16 | Advanced Cardiovascular Systems, Inc. | Multilayer stent |
DE29904817U1 (en) | 1999-03-16 | 1999-05-27 | Amg Handelsgesellschaft Fuer A | Blood vessel support device |
US6364903B2 (en) | 1999-03-19 | 2002-04-02 | Meadox Medicals, Inc. | Polymer coated stent |
US6325825B1 (en) | 1999-04-08 | 2001-12-04 | Cordis Corporation | Stent with variable wall thickness |
CA2370180C (en) | 1999-04-15 | 2009-07-07 | Smart Therapeutics, Inc. | Intravascular stent and method of treating neurovascular vessel lesion |
US6730116B1 (en) | 1999-04-16 | 2004-05-04 | Medtronic, Inc. | Medical device for intraluminal endovascular stenting |
US6273911B1 (en) | 1999-04-22 | 2001-08-14 | Advanced Cardiovascular Systems, Inc. | Variable strength stent |
US6375676B1 (en) | 1999-05-17 | 2002-04-23 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with enhanced delivery precision and stent delivery system |
US6673103B1 (en) | 1999-05-20 | 2004-01-06 | Scimed Life Systems, Inc. | Mesh and stent for increased flexibility |
EP1180003B1 (en) | 1999-05-20 | 2008-01-16 | Boston Scientific Limited | Stent delivery system with nested stabilizer |
US6398802B1 (en) | 1999-06-21 | 2002-06-04 | Scimed Life Systems, Inc. | Low profile delivery system for stent and graft deployment |
US6312459B1 (en) | 1999-06-30 | 2001-11-06 | Advanced Cardiovascular Systems, Inc. | Stent design for use in small vessels |
US6258121B1 (en) | 1999-07-02 | 2001-07-10 | Scimed Life Systems, Inc. | Stent coating |
US6551351B2 (en) | 1999-07-02 | 2003-04-22 | Scimed Life Systems | Spiral wound stent |
US6409754B1 (en) | 1999-07-02 | 2002-06-25 | Scimed Life Systems, Inc. | Flexible segmented stent |
US6780497B1 (en) | 1999-08-05 | 2004-08-24 | Gore Enterprise Holdings, Inc. | Surface modified expanded polytetrafluoroethylene devices and methods of producing the same |
US6299622B1 (en) | 1999-08-19 | 2001-10-09 | Fox Hollow Technologies, Inc. | Atherectomy catheter with aligned imager |
US6514268B2 (en) | 1999-08-30 | 2003-02-04 | Alcon Universal Ltd. | Method of operating microsurgical instruments |
US6293968B1 (en) | 1999-09-02 | 2001-09-25 | Syde A. Taheri | Inflatable intraluminal vascular stent |
US6503556B2 (en) | 2000-12-28 | 2003-01-07 | Advanced Cardiovascular Systems, Inc. | Methods of forming a coating for a prosthesis |
US6790228B2 (en) | 1999-12-23 | 2004-09-14 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US6383213B2 (en) | 1999-10-05 | 2002-05-07 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
FR2799363B1 (en) | 1999-10-11 | 2001-11-30 | Braun Celsa Sa | MEDICAL IMPLANT IN MEANDRES IN ZIGZAG |
US20010047200A1 (en) | 1999-10-13 | 2001-11-29 | Raymond Sun | Non-foreshortening intraluminal prosthesis |
US6420378B1 (en) | 1999-10-15 | 2002-07-16 | Supergen, Inc. | Inhibition of abnormal cell proliferation with camptothecin and combinations including the same |
US6331189B1 (en) | 1999-10-18 | 2001-12-18 | Medtronic, Inc. | Flexible medical stent |
DE19951477A1 (en) | 1999-10-26 | 2001-05-03 | Biotronik Mess & Therapieg | Stent |
DE19951611A1 (en) | 1999-10-26 | 2001-05-10 | Biotronik Mess & Therapieg | Stent with a closed structure |
US6428569B1 (en) | 1999-11-09 | 2002-08-06 | Scimed Life Systems Inc. | Micro structure stent configurations |
US6679910B1 (en) | 1999-11-12 | 2004-01-20 | Latin American Devices Llc | Intraluminal stent |
US6280466B1 (en) | 1999-12-03 | 2001-08-28 | Teramed Inc. | Endovascular graft system |
US6673107B1 (en) | 1999-12-06 | 2004-01-06 | Advanced Cardiovascular Systems, Inc. | Bifurcated stent and method of making |
US6387120B2 (en) | 1999-12-09 | 2002-05-14 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US6702849B1 (en) | 1999-12-13 | 2004-03-09 | Advanced Cardiovascular Systems, Inc. | Method of processing open-celled microcellular polymeric foams with controlled porosity for use as vascular grafts and stent covers |
US6338739B1 (en) | 1999-12-22 | 2002-01-15 | Ethicon, Inc. | Biodegradable stent |
US6981987B2 (en) | 1999-12-22 | 2006-01-03 | Ethicon, Inc. | Removable stent for body lumens |
US6908624B2 (en) | 1999-12-23 | 2005-06-21 | Advanced Cardiovascular Systems, Inc. | Coating for implantable devices and a method of forming the same |
US6471721B1 (en) | 1999-12-30 | 2002-10-29 | Advanced Cardiovascular Systems, Inc. | Vascular stent having increased radiopacity and method for making same |
US6537311B1 (en) | 1999-12-30 | 2003-03-25 | Advanced Cardiovascular Systems, Inc. | Stent designs for use in peripheral vessels |
US6942674B2 (en) | 2000-01-05 | 2005-09-13 | Integrated Vascular Systems, Inc. | Apparatus and methods for delivering a closure device |
US6322586B1 (en) | 2000-01-10 | 2001-11-27 | Scimed Life Systems, Inc. | Catheter tip designs and method of manufacture |
US6312458B1 (en) | 2000-01-19 | 2001-11-06 | Scimed Life Systems, Inc. | Tubular structure/stent/stent securement member |
US6355063B1 (en) | 2000-01-20 | 2002-03-12 | Impra, Inc. | Expanded PTFE drug delivery graft |
US6344044B1 (en) | 2000-02-11 | 2002-02-05 | Edwards Lifesciences Corp. | Apparatus and methods for delivery of intraluminal prosthesis |
US6723119B2 (en) | 2000-03-01 | 2004-04-20 | Medinol Ltd. | Longitudinally flexible stent |
SG86458A1 (en) | 2000-03-01 | 2002-02-19 | Medinol Ltd | Longitudinally flexible stent |
EP1132060A2 (en) | 2000-03-09 | 2001-09-12 | LPL Systems Inc. | Expandable stent |
WO2001066035A2 (en) * | 2000-03-09 | 2001-09-13 | Diseno Y Desarrollo Medico, S.A. De C.V. | Stent with cover connectors |
US6736838B1 (en) | 2000-03-22 | 2004-05-18 | Zuli Holdings Ltd. | Method and apparatus for covering a stent |
US6953476B1 (en) * | 2000-03-27 | 2005-10-11 | Neovasc Medical Ltd. | Device and method for treating ischemic heart disease |
US6818247B1 (en) | 2000-03-31 | 2004-11-16 | Advanced Cardiovascular Systems, Inc. | Ethylene vinyl alcohol-dimethyl acetamide composition and a method of coating a stent |
WO2001076675A2 (en) | 2000-04-11 | 2001-10-18 | Scimed Life Systems, Inc. | Reinforced retention structures |
GB0009030D0 (en) | 2000-04-12 | 2000-05-31 | Angiomed Ag | Self-expanding metal stent and method of making it |
JP3654627B2 (en) | 2000-04-20 | 2005-06-02 | 川澄化学工業株式会社 | Stent |
AU781306B2 (en) | 2000-05-02 | 2005-05-12 | Cordis Corporation | Bifurcated stent and stent delivery system |
US6352552B1 (en) | 2000-05-02 | 2002-03-05 | Scion Cardio-Vascular, Inc. | Stent |
US6616689B1 (en) | 2000-05-03 | 2003-09-09 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US6776796B2 (en) | 2000-05-12 | 2004-08-17 | Cordis Corportation | Antiinflammatory drug and delivery device |
US6423091B1 (en) | 2000-05-16 | 2002-07-23 | Cordis Corporation | Helical stent having flat ends |
KR100360364B1 (en) | 2000-05-22 | 2002-11-13 | 주식회사 정성메디칼 | A metal stent for installation in the coronary artery |
US6764519B2 (en) | 2000-05-26 | 2004-07-20 | Scimed Life Systems, Inc. | Ureteral stent |
US20030139803A1 (en) | 2000-05-30 | 2003-07-24 | Jacques Sequin | Method of stenting a vessel with stent lumenal diameter increasing distally |
US6800089B1 (en) | 2000-05-31 | 2004-10-05 | Advanced Cardiovascular Systems, Inc. | Mechanical attachment method of cover materials on stents |
US6572646B1 (en) | 2000-06-02 | 2003-06-03 | Advanced Cardiovascular Systems, Inc. | Curved nitinol stent for extremely tortuous anatomy |
US6719991B2 (en) | 2000-06-09 | 2004-04-13 | Baylor College Of Medicine | Combination of antimicrobial agents and bacterial interference to coat medical devices |
US6723373B1 (en) | 2000-06-16 | 2004-04-20 | Cordis Corporation | Device and process for coating stents |
US6652579B1 (en) | 2000-06-22 | 2003-11-25 | Advanced Cardiovascular Systems, Inc. | Radiopaque stent |
US6805704B1 (en) | 2000-06-26 | 2004-10-19 | C. R. Bard, Inc. | Intraluminal stents |
US6540775B1 (en) | 2000-06-30 | 2003-04-01 | Cordis Corporation | Ultraflexible open cell stent |
DE10033723C1 (en) | 2000-07-12 | 2002-02-21 | Siemens Ag | Surgical instrument position and orientation visualization device for surgical operation has data representing instrument position and orientation projected onto surface of patient's body |
US6709451B1 (en) | 2000-07-14 | 2004-03-23 | Norman Noble, Inc. | Channeled vascular stent apparatus and method |
US6440162B1 (en) | 2000-07-26 | 2002-08-27 | Advanced Cardiovascular Systems, Inc. | Stent having increased scaffolding expandable bar arms |
US6808533B1 (en) | 2000-07-28 | 2004-10-26 | Atrium Medical Corporation | Covered stent and method of covering a stent |
US6773446B1 (en) | 2000-08-02 | 2004-08-10 | Cordis Corporation | Delivery apparatus for a self-expanding stent |
US6613078B1 (en) | 2000-08-02 | 2003-09-02 | Hector Daniel Barone | Multi-component endoluminal graft assembly, use thereof and method of implanting |
US7141038B2 (en) | 2000-08-07 | 2006-11-28 | Abbeymoor Medical, Inc. | Endourethral device and method |
WO2002015824A2 (en) | 2000-08-25 | 2002-02-28 | Kensey Nash Corporation | Covered stents, systems for deploying covered stents |
NO312223B1 (en) | 2000-09-05 | 2002-04-15 | Leiv Eiriksson Nyfotek As | Coated expandable stent |
US6478815B1 (en) | 2000-09-18 | 2002-11-12 | Inflow Dynamics Inc. | Vascular and endoluminal stents |
US6554841B1 (en) | 2000-09-22 | 2003-04-29 | Scimed Life Systems, Inc. | Striped sleeve for stent delivery |
US6669722B2 (en) | 2000-09-22 | 2003-12-30 | Cordis Corporation | Stent with optimal strength and radiopacity characteristics |
EP1328212B1 (en) | 2000-09-25 | 2007-01-03 | Boston Scientific Scimed, Inc. | Intravascular stent apparatus |
US6695833B1 (en) | 2000-09-27 | 2004-02-24 | Nellix, Inc. | Vascular stent-graft apparatus and forming method |
US6805898B1 (en) | 2000-09-28 | 2004-10-19 | Advanced Cardiovascular Systems, Inc. | Surface features of an implantable medical device |
US6485508B1 (en) | 2000-10-13 | 2002-11-26 | Mcguinness Colm P. | Low profile stent |
US6764507B2 (en) | 2000-10-16 | 2004-07-20 | Conor Medsystems, Inc. | Expandable medical device with improved spatial distribution |
US6786918B1 (en) | 2000-10-17 | 2004-09-07 | Medtronic Vascular, Inc. | Stent delivery system |
US6663664B1 (en) | 2000-10-26 | 2003-12-16 | Advanced Cardiovascular Systems, Inc. | Self-expanding stent with time variable radial force |
US6758859B1 (en) | 2000-10-30 | 2004-07-06 | Kenny L. Dang | Increased drug-loading and reduced stress drug delivery device |
US6770086B1 (en) | 2000-11-02 | 2004-08-03 | Scimed Life Systems, Inc. | Stent covering formed of porous polytetraflouroethylene |
WO2002038080A2 (en) | 2000-11-07 | 2002-05-16 | Advanced Bio Prosthetic Surfaces, Ltd. | Endoluminal stent, self-fupporting endoluminal graft and methods of making same |
US6843802B1 (en) | 2000-11-16 | 2005-01-18 | Cordis Corporation | Delivery apparatus for a self expanding retractable stent |
US6664335B2 (en) | 2000-11-30 | 2003-12-16 | Cardiac Pacemakers, Inc. | Polyurethane elastomer article with “shape memory” and medical devices therefrom |
US6645242B1 (en) | 2000-12-11 | 2003-11-11 | Stephen F. Quinn | Bifurcated side-access intravascular stent graft |
US6913617B1 (en) | 2000-12-27 | 2005-07-05 | Advanced Cardiovascular Systems, Inc. | Method for creating a textured surface on an implantable medical device |
US6569194B1 (en) | 2000-12-28 | 2003-05-27 | Advanced Cardiovascular Systems, Inc. | Thermoelastic and superelastic Ni-Ti-W alloy |
US6565599B1 (en) | 2000-12-28 | 2003-05-20 | Advanced Cardiovascular Systems, Inc. | Hybrid stent |
US6540776B2 (en) | 2000-12-28 | 2003-04-01 | Advanced Cardiovascular Systems, Inc. | Sheath for a prosthesis and methods of forming the same |
US6641607B1 (en) | 2000-12-29 | 2003-11-04 | Advanced Cardiovascular Systems, Inc. | Double tube stent |
US6749627B2 (en) | 2001-01-18 | 2004-06-15 | Ev3 Peripheral, Inc. | Grip for stent delivery system |
US6899727B2 (en) | 2001-01-22 | 2005-05-31 | Gore Enterprise Holdings, Inc. | Deployment system for intraluminal devices |
US6752829B2 (en) | 2001-01-30 | 2004-06-22 | Scimed Life Systems, Inc. | Stent with channel(s) for containing and delivering a biologically active material and method for manufacturing the same |
JP4819245B2 (en) | 2001-05-25 | 2011-11-24 | 株式会社カネカ | Stent |
US20040102834A1 (en) | 2001-02-01 | 2004-05-27 | Ryoji Nakano | Stent |
US6802846B2 (en) | 2001-02-12 | 2004-10-12 | Ams Research Corporation | Foreign body retrieval device and method |
US6540777B2 (en) | 2001-02-15 | 2003-04-01 | Scimed Life Systems, Inc. | Locking stent |
US6623518B2 (en) | 2001-02-26 | 2003-09-23 | Ev3 Peripheral, Inc. | Implant delivery system with interlock |
US6942689B2 (en) | 2001-03-01 | 2005-09-13 | Cordis Corporation | Flexible stent |
US6790227B2 (en) | 2001-03-01 | 2004-09-14 | Cordis Corporation | Flexible stent |
US6679911B2 (en) | 2001-03-01 | 2004-01-20 | Cordis Corporation | Flexible stent |
US6673104B2 (en) | 2001-03-15 | 2004-01-06 | Scimed Life Systems, Inc. | Magnetic stent |
US6673105B1 (en) | 2001-04-02 | 2004-01-06 | Advanced Cardiovascular Systems, Inc. | Metal prosthesis coated with expandable ePTFE |
US6756007B2 (en) | 2001-04-04 | 2004-06-29 | Bard Peripheral Vascular, Inc. | Method for preparing an implantable prosthesis for loading into a delivery apparatus |
US6764505B1 (en) | 2001-04-12 | 2004-07-20 | Advanced Cardiovascular Systems, Inc. | Variable surface area stent |
US7011675B2 (en) | 2001-04-30 | 2006-03-14 | Boston Scientific Scimed, Inc. | Endoscopic stent delivery system and method |
US6660034B1 (en) | 2001-04-30 | 2003-12-09 | Advanced Cardiovascular Systems, Inc. | Stent for increasing blood flow to ischemic tissues and a method of using the same |
US6685745B2 (en) | 2001-05-15 | 2004-02-03 | Scimed Life Systems, Inc. | Delivering an agent to a patient's body |
US6749628B1 (en) | 2001-05-17 | 2004-06-15 | Advanced Cardiovascular Systems, Inc. | Stent and catheter assembly and method for treating bifurcations |
US7087088B2 (en) * | 2001-05-24 | 2006-08-08 | Torax Medical, Inc. | Methods and apparatus for regulating the flow of matter through body tubing |
US6821291B2 (en) | 2001-06-01 | 2004-11-23 | Ams Research Corporation | Retrievable stent and method of use thereof |
US6712844B2 (en) | 2001-06-06 | 2004-03-30 | Advanced Cardiovascular Systems, Inc. | MRI compatible stent |
US6629994B2 (en) | 2001-06-11 | 2003-10-07 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US6673106B2 (en) | 2001-06-14 | 2004-01-06 | Cordis Neurovascular, Inc. | Intravascular stent device |
US6818013B2 (en) | 2001-06-14 | 2004-11-16 | Cordis Corporation | Intravascular stent device |
US6749629B1 (en) | 2001-06-27 | 2004-06-15 | Advanced Cardiovascular Systems, Inc. | Stent pattern with figure-eights |
US6676693B1 (en) | 2001-06-27 | 2004-01-13 | Advanced Cardiovascular Systems, Inc. | Apparatus and method for delivering a self-expanding stent |
US6695920B1 (en) | 2001-06-27 | 2004-02-24 | Advanced Cardiovascular Systems, Inc. | Mandrel for supporting a stent and a method of using the mandrel to coat a stent |
US6673154B1 (en) | 2001-06-28 | 2004-01-06 | Advanced Cardiovascular Systems, Inc. | Stent mounting device to coat a stent |
US6656216B1 (en) | 2001-06-29 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Composite stent with regioselective material |
EP1273314A1 (en) | 2001-07-06 | 2003-01-08 | Terumo Kabushiki Kaisha | Stent |
WO2003009773A2 (en) | 2001-07-26 | 2003-02-06 | Alveolus Inc. | Removable stent and method of using the same |
US20030040803A1 (en) | 2001-08-23 | 2003-02-27 | Rioux Robert F. | Maintaining an open passageway through a body lumen |
KR100455343B1 (en) * | 2001-08-29 | 2004-11-12 | 학교법인 인하학원 | Covering composition for drug releasing stent and drug releasing stent manufactured using same |
US6908480B2 (en) | 2001-08-29 | 2005-06-21 | Swaminathan Jayaraman | Structurally variable stents |
US6641611B2 (en) | 2001-11-26 | 2003-11-04 | Swaminathan Jayaraman | Therapeutic coating for an intravascular implant |
US6656351B2 (en) | 2001-08-31 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Embolic protection devices one way porous membrane |
US6805703B2 (en) | 2001-09-18 | 2004-10-19 | Scimed Life Systems, Inc. | Protective membrane for reconfiguring a workpiece |
US6753071B1 (en) | 2001-09-27 | 2004-06-22 | Advanced Cardiovascular Systems, Inc. | Rate-reducing membrane for release of an agent |
DE60223886T2 (en) | 2001-10-22 | 2008-11-06 | Terumo K.K. | STENT AND METHOD FOR THE PRODUCTION THEREOF |
US20030077310A1 (en) | 2001-10-22 | 2003-04-24 | Chandrashekhar Pathak | Stent coatings containing HMG-CoA reductase inhibitors |
US20030083734A1 (en) | 2001-10-25 | 2003-05-01 | Curative Ag | Stent |
US6712843B2 (en) | 2001-11-20 | 2004-03-30 | Scimed Life Systems, Inc | Stent with differential lengthening/shortening members |
US6776794B1 (en) | 2001-11-28 | 2004-08-17 | Advanced Cardiovascular Systems, Inc. | Stent pattern with mirror image |
US7014654B2 (en) | 2001-11-30 | 2006-03-21 | Scimed Life Systems, Inc. | Stent designed for the delivery of therapeutic substance or other agents |
US20030114919A1 (en) | 2001-12-10 | 2003-06-19 | Mcquiston Jesse | Polymeric stent with metallic rings |
US6752826B2 (en) | 2001-12-14 | 2004-06-22 | Thoratec Corporation | Layered stent-graft and methods of making the same |
US6866805B2 (en) | 2001-12-27 | 2005-03-15 | Advanced Cardiovascular Systems, Inc. | Hybrid intravascular stent |
US6805707B1 (en) | 2001-12-27 | 2004-10-19 | Advanced Cardiovascular Systems, Inc. | Stent with improved ring and link pattern |
US7163553B2 (en) | 2001-12-28 | 2007-01-16 | Advanced Cardiovascular Systems, Inc. | Intravascular stent and method of use |
US6893413B2 (en) | 2002-01-07 | 2005-05-17 | Eric C. Martin | Two-piece stent combination for percutaneous arterialization of the coronary sinus and retrograde perfusion of the myocardium |
US6981985B2 (en) | 2002-01-22 | 2006-01-03 | Boston Scientific Scimed, Inc. | Stent bumper struts |
US7029493B2 (en) | 2002-01-25 | 2006-04-18 | Cordis Corporation | Stent with enhanced crossability |
US6989024B2 (en) | 2002-02-28 | 2006-01-24 | Counter Clockwise, Inc. | Guidewire loaded stent for delivery through a catheter |
US6773448B2 (en) | 2002-03-08 | 2004-08-10 | Ev3 Inc. | Distal protection devices having controllable wire motion |
GB0206061D0 (en) * | 2002-03-14 | 2002-04-24 | Angiomed Ag | Metal structure compatible with MRI imaging, and method of manufacturing such a structure |
US20030187495A1 (en) | 2002-04-01 | 2003-10-02 | Cully Edward H. | Endoluminal devices, embolic filters, methods of manufacture and use |
US6911039B2 (en) | 2002-04-23 | 2005-06-28 | Medtronic Vascular, Inc. | Integrated mechanical handle with quick slide mechanism |
DE10221076A1 (en) | 2002-05-11 | 2003-11-27 | Ruesch Willy Gmbh | stent |
US6830638B2 (en) | 2002-05-24 | 2004-12-14 | Advanced Cardiovascular Systems, Inc. | Medical devices configured from deep drawn nickel-titanium alloys and nickel-titanium clad alloys and method of making the same |
US6656220B1 (en) * | 2002-06-17 | 2003-12-02 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US7044962B2 (en) | 2002-06-25 | 2006-05-16 | Scimed Life Systems, Inc. | Implantable prosthesis with displaceable skirt |
US6761731B2 (en) | 2002-06-28 | 2004-07-13 | Cordis Corporation | Balloon-stent interaction to help reduce foreshortening |
US6802859B1 (en) | 2002-07-12 | 2004-10-12 | Endovascular Technologies, Inc. | Endovascular stent-graft with flexible bifurcation |
EP1585535A2 (en) | 2002-08-15 | 2005-10-19 | Osteotrophin LLC | Pthrp-derived modulators of smooth muscle proliferation |
AU2003258240A1 (en) | 2002-08-15 | 2004-03-03 | Gmp Cardiac Care, Inc | Stent-graft with rails |
US6878162B2 (en) | 2002-08-30 | 2005-04-12 | Edwards Lifesciences Ag | Helical stent having improved flexibility and expandability |
US20040059406A1 (en) | 2002-09-20 | 2004-03-25 | Cully Edward H. | Medical device amenable to fenestration |
US6818063B1 (en) | 2002-09-24 | 2004-11-16 | Advanced Cardiovascular Systems, Inc. | Stent mandrel fixture and method for minimizing coating defects |
US6821293B2 (en) | 2002-10-25 | 2004-11-23 | Medinol Ltd. | Mandrel and method for making stents |
US7637942B2 (en) | 2002-11-05 | 2009-12-29 | Merit Medical Systems, Inc. | Coated stent with geometry determinated functionality and method of making the same |
JP5211272B2 (en) | 2002-11-22 | 2013-06-12 | クック メディカル テクノロジーズ エルエルシー | Stent tissue graft prosthesis |
US6899729B1 (en) | 2002-12-18 | 2005-05-31 | Advanced Cardiovascular Systems, Inc. | Stent for treating vulnerable plaque |
US6896697B1 (en) | 2002-12-30 | 2005-05-24 | Advanced Cardiovascular Systems, Inc. | Intravascular stent |
US6920677B2 (en) | 2003-02-27 | 2005-07-26 | Medtronic Vascular, Inc. | Method for manufacturing an endovascular support device |
US6984244B2 (en) | 2003-03-27 | 2006-01-10 | Endovascular Technologies, Inc. | Delivery system for endoluminal implant |
US7279003B2 (en) | 2003-04-24 | 2007-10-09 | Medtronic Vascular, Inc. | Stent graft tapered spring |
CA2524651A1 (en) | 2003-05-15 | 2004-12-02 | Applied Medical Resources Corporation | Echogenic stent |
US6979348B2 (en) | 2003-06-04 | 2005-12-27 | Medtronic Vascular, Inc. | Reflowed drug-polymer coated stent and method thereof |
US6916336B2 (en) | 2003-06-09 | 2005-07-12 | Avantec Vascular Corporation | Vascular prosthesis |
-
2003
- 2003-09-30 US US10/674,972 patent/US7875068B2/en active Active
-
2004
- 2004-09-29 EP EP04785241A patent/EP1684680A4/en not_active Withdrawn
- 2004-09-29 AU AU2004277973A patent/AU2004277973A1/en not_active Abandoned
- 2004-09-29 CA CA002540676A patent/CA2540676A1/en not_active Abandoned
- 2004-09-29 WO PCT/US2004/031906 patent/WO2005032415A2/en active Application Filing
- 2004-09-29 JP JP2006534046A patent/JP2007532145A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2004277973A1 (en) | 2005-04-14 |
US20040127973A1 (en) | 2004-07-01 |
EP1684680A4 (en) | 2008-06-18 |
EP1684680A2 (en) | 2006-08-02 |
WO2005032415A2 (en) | 2005-04-14 |
US7875068B2 (en) | 2011-01-25 |
WO2005032415A3 (en) | 2007-05-31 |
JP2007532145A (en) | 2007-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7875068B2 (en) | Removable biliary stent | |
EP1558178B1 (en) | Stent with geometry determinated functionality and method of making the same | |
CA2540148C (en) | Covered stent with geometry determinated functionality and method of making the same | |
AU2005269663B2 (en) | Stent with an end member having a lateral extension | |
US7247166B2 (en) | Intravascular stent with extendible end rings | |
JP4871692B2 (en) | In vivo indwelling stent and biological organ dilator | |
US7399312B2 (en) | Stent design with sheath attachment members | |
US7959671B2 (en) | Differential covering and coating methods | |
US9320628B2 (en) | Endoprosthesis devices including biostable and bioabsorable regions | |
EP1689328A1 (en) | Differential covering and coating methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |